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ABSTRACT 
 
BINARY MIXTURES OF PYRETHROIDS INTERACT WITH VOLTAGE-
SENSITIVE CALCIUM AND CHLORIDE CHANNELS IN ISOLATED 
PRESYNAPTIC NERVE TERMINALS FROM RAT BRAIN 
 
SEPTEMBER 2008 
 
HILLIARY E. HODGDON 
 
 B.S., UNIVERSITY OF MASSACHUSETTS-AMHERST 
 
M.S., UNIVERSITY OF MASSACHUSETTS-AMHERST 
 
Directed by: John M. Clark 
 
 
 
Select pyrethroid binary mixtures (deltamethrin plus S-bioallethrin, β-cyfluthrin, 
cypermethrin, and fenpropathrin) elicit a more-than-additive response on L-glutamate 
release from rat brain synaptosomes that is independent of calcium influx.  Using a 
variety of chloride channel antagonists, anthracene-9-carboxylic acid (9-AC), 
rChlorotoxin (ClTx), 4,4’-dintitrostilbene-2,2’-disulfonic acid (DNDS), 5-nitro-2-(3-
phenylpropylamino) benzoic acid (NPPB), and picrotoxinin (PTX), we have identified 
two mechanisms by which pyrethroids may enhance L-glutamate release.  The results 
from this study indicate that only ClTx and NPPB, at their EC50s (0.1 µM and 70 µM, 
respectively), significantly increase L-glutamate release when in the presence of our most 
potent pyrethroid, deltamethrin, at its EC50 (2 x 10-12 M).  When these two antagonists 
were used in the presence of deltamethrin plus cypermethrin and deltamethrin plus 
fenpropathrin, a more-than-additive response was elicited at lower concentrations of the 
binary mixtures.  Likewise, NPPB in the presence of the additive binary mixture, 
deltamethrin plus tefluthrin, first elicited a more-than-additive response at the 1:10 
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mixture.  Since both ClTx and NPPB are inhibitors of voltage-gated chloride channels 
(ClC-2) and calcium-activated chloride channels, our findings suggest that these channels 
are potential target sites for certain pyrethroids and likely are important in pyrethroid 
neurotoxicity.  
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 CHAPTER 1 
 
 
INTRODUCTION 
 
 
1.1 Regulatory History of Pyrethroids 
 
 
 The United States Environmental Protection Agency (USEPA) regulates pesticides 
under two major statutes: the Federal Insecticide, Fungicide, and Rodenticide Act 
(FIFRA) and the Federal Food, Drug, and Cosmetic Act (FFDCA).  Under FIFRA, the 
EPA is responsible for registering pesticides for use in the United States and prescribing 
regulatory requirements to prevent unreasonable adverse effects on human health and the 
environment while the FFDCA requires the EPA to establish tolerances for pesticide 
residues in food (United States Environmental Protection Agency 2007c).  In 1996, 
Congress passed the Food Quality Protection Act (FQPA) that mandated the USEPA to 
complete the review and reassessment of the tolerances (maximum legally permissible 
levels) for all food use pesticides within a decade (United States Environmental 
Protection Agency 2007c).   
 Since the enactment of the FQPA, many efforts have been made to update and 
resolve inconsistencies between the two major pesticide statutes by establishing a more 
consistent and protective regulatory scheme including, a mandate of a single, health-
based standard for all pesticides in all foods, an expansion of the scope of protection for 
infants and children, and a reassessment of the safety of existing tolerances and tolerance 
exemptions (United States Environmental Protection Agency 2007a). 
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 N-methyl carbamates and organophosphates are among the classes of pesticides 
being reassessed under the FQPA for cumulative risk since some share a common 
mechanism of toxicity (e.g., act the same way to produce toxicity).   In conducting these 
cumulative risk assessments, the EPA must evaluate the potential for a person to be 
exposed to more than one compound from food, drinking water, and residential sources 
(United States Environmental Protection Agency 2007b).  
 Thus far, findings from the cumulative risk assessments have led to the 
discontinued or restricted use of certain pesticides from the carbamate and 
organophosphate classes of insecticides (United States Environmental Protection Agency 
2007a, United States Environmental Protection Agency 2006).  It is expected that the use 
of other control agents, specifically the pyrethroid insecticides, will increase in order to 
ensure and maintain agricultural productivity and control of insect vectors of human and 
animal diseases. 
Pyrethroids account for approximately one quarter of the worldwide insecticide 
market and have been used since the 1970s as control agents in urban areas and to control 
insects that vector diseases such as malaria, dengue fever, and West Nile virus (Casida, 
J.E. 1998; Narahashi, T. 1992; Trainer, V.L. 1997; Takken, W. 2002).  Pyrethroids are 
synthetic insecticides that were optimized based on the structures of the six naturally-
occurring pyrethrin esters of the pyrethrum extract derived from the flower heads of 
Chrysanthemum cinerariaefolium (Soderlund, D.M. 2002).  For almost two centuries, 
pyrethrum was the most important botanical insecticide because of its potency and 
selectivity to insects.  Pyrethrum, however, is highly susceptible to hydrolytic ester 
cleavage and is unstable in light and air, greatly diminishing its effectiveness as a field 
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stable insecticide (Casida, J.E. 1998; Soderlund, D.M. 2002).  The development of 
synthetic pyrethroids was the result of efforts to increase their photostability and acute 
neurotoxicity in insects by altering either the cyclopropanecarboxylic acid or 
cyclopentenolone alcohol moieties of the pyrethrin esters (Fig. 1) (Soderlund, D.M. 
2002).  In fact, mammals are three orders of magnitude less sensitive to the toxic action 
of pyrethroids than insects owing to their rapid metabolism, poor absorption, higher body 
temperature (pyrethroids have a negative temperature coefficient of action), and lower 
sensitivity of ion channel target sites (Clark, J.M. 1994; Narahashi, T. 1992; Soderlund, 
D.M. 1989; Ray, D.E. 2006).  Given the high risk of exposure due to the widespread use 
of pyrethroids in agriculture and public health and the potential for their usage to 
increase, the EPA must likewise consider the cumulative risk of pyrethroids in mammals 
under the FQPA criteria.  
 
 
Figure 1. The chemical structure of pyrethrin I, the most toxic ester of pyrethrum.  This 
structure is the basis for all pyrethroids (reproduced from Soderlund 2002). 
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Overall, the entire molecular shape and stereospecificity of pyrethroids rather than 
a specific substructure, reactive entity, or molecular moiety of the compound, are 
responsible for pyrethroid toxicity (Elliott, M. et al. 1974; Soderlund, D.M. 200).  The 
acute neurotoxicity of pyrethroids has been well characterized and an initial classification 
based on their symptomology in rats has been established (Verschoyle, R.D. 1980; 
Shafer, T.J. 2005).  Pyrethroids producing hypersensitivity, aggression, convulsions, and 
fine tremor progressing to whole-body tremor were termed tremor (T) syndrome.  
Pyrethroids producing pawing and burrowing, salivation, and coarse tremor progressing 
to choreoathetosis (sinuous writhing convulsions) were termed choreoathetosis with 
salivation (CS) syndrome (Verschoyle, R.D. and Barnes, J.M. 1972; Lawrence, L.J. 1982; 
Gammon, D.W. 1981).  An alternative nomenclature for pyrethroids was later proposed 
based on their chemical structures and their toxicological effects produced in insects.  
Pyrethroids containing an α-cyano-3-phenoxybenzyl alcohol group were called Type II 
pyrethroids whereas compounds lacking an α-cyano group were called Type I pyrethroids 
(Lawrence, L.J. 1982; Gammon, D.W. 1981).  Although the Type I/II nomenclature has 
been widely adopted in literature and is often used synonymously with the T/CS 
syndrome terminology respectively, some pyrethroids exhibit an intermediate syndrome 
composed of both T and CS syndromes, some Type I pyrethroids elicit the CS-syndrome 
(permethrin), and some Type II pyrethroids elicit the T-syndrome (fenpropathrin) 
(Verschoyle, R.D. 1980; Lawrence, L.J. 1982; Soderlund, D.M. 2002).   
In the 1970s, Aldridge et al. demonstrated that the in vivo action of deltamethrin 
(CS-syndrome pyrethroid) on the nervous system was different from that of cismethrin 
(T-syndrome pyrethroid) and DDT.  After treating rats orally with DDT, cismethrin, and 
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deltamethrin, they found that deltamethrin caused a 52% decrease in acetylcholine 
content of the brain and cerebellum whereas DDT and cismethrin caused no significant 
reduction in the amount of neurotransmitter present (Aldridge, W.N. 1978).  A more 
recent study conducted on freely moving rats validated this in vivo finding and showed 
that deltamethrin caused a concentration-dependent efflux of acetylcholine at the onset of 
the CS symptomology (Hossain, M.M. 2004).  Collectively, these findings suggested that 
CS-syndrome pyrethroids act differently at the presynaptic nerve terminal than T-
syndrome pyrethroids.  This difference may be responsible for the different neurotoxic 
action of CS-syndrome pyrethroids versus T-syndrome pyrethroids (Ray, D.E. 1979).   
Over the past three decades, voltage-gated sodium channels (VGSC) in nerve 
axons have been well documented as a principal site of action of all pyrethroids in both 
insects and mammals (Soderlund, D.M. 1989; Narahashi, T. 1992; Soderlund, D.M. 
2000).  Intracellular recordings of action potentials in nerve axons demonstrated that 
pyrethroids produce two distinct types of effects on nerve excitability depending on the 
structure of the pyrethroid.  Type I poisoning is characterized by a slowing of VGSC 
inactivation, resulting in a depolarizing after potential (DAP) due to an increase in “late 
current”.  The DAP results in the spontaneous firing in action potentials and ultimately 
long trains of  repetitive discharges, which are directly correlated to the tremors produced 
by T-syndrome pyrethroids and are qualitatively similar, if not identical, to the actions of 
the well established VGSC agonist, DDT (Narahashi, T. 1960; Lund, A.E. 1983; 
Soderlund, D.M. 2000; Narahashi, T. 1992; Ray, D.E. 2006).  Type II pyrethroids that 
produce the CS-syndrome most noticeably slow the deactivation kinetics of VGSCs, 
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resulting in a prolonged sodium tail current that eventually causes conduction block 
(Shafer, T.J. 2005; Soderlund, D.M. 2002).   
In addition to VGSCs, ATPases, L-glutamate receptors, acetylcholine receptors, 
gamma aminobutyric acid (GABA) gated chloride channels, voltage-gated calcium 
channels (VGCCs) and chloride channels (VGClCs) have been identified as potential 
molecular targets of pyrethroid activity (Soderlund, D.M. 2002).  Only the latter two 
(VGCCs and VGClCs), however, are altered by relatively low concentrations of 
pyrethroids, elicit stereospecific actions, and have been implicated in the acute 
neurotoxicological response in functional assays (Hildebrand, M.E. 2004; Ray, D.E. 
2000; Soderlund, D.M. 2002; Symington, S.B. 2007b).   
Evidence for VGCCs as a site of action for pyrethroids at the presynaptic nerve 
terminal has been demonstrated using isolated presynaptic nerve terminals 
(synaptosomes) from rat brain (Symington, S.B. 2007b).  Upon depolarization, both 
cismethrin, a T-syndrome pyrethroid, and 1R-deltamethrin, a CS-syndrome pyrethroid, 
resulted in a concentration-dependent increase in calcium influx whereas their inactive 
stereoisomers, bioresmethrin and 1S-deltamethrin respectively, did not (Symington, S.B. 
2007b).  Furthermore, though both cismethrin and 1R-deltamethrin stimulated calcium 
influx, only 1R-deltamethrin enhanced Ca2+-dependent neurotransmitter (L-glutamate) 
release.  L-glutamate release was stimulated by K+ depolarization, unaltered by the 
VGSC antagonist, tetrodotoxin, and blocked by ω-conotoxin GVIA, the N-type calcium 
channel antagonist, implicating the N-type VGCCs as target sites for CS-syndrome 
pyrethroids (Clark, J.M. 2007).   
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The stereospecific action of pyrethroids was further validated using 
heterologously expressed CaV2.2 (N-type calcium channel from rat brain) in Xenopus 
laevis oocytes.  Contrary to their findings in synaptosomes, Clark found that 1R-
deltamethrin reduced peak current in a concentration-dependent manner via wild-type 
channels (T422) while the inactive stereoisomer, 1S-deltamethrin, had no effect.  In a 
permanently phosphorylated form of CaV2.2 (T422E mutant), however, peak current 
increased in the presence of 1R-deltamethrin while 1S-deltamethrin had no significant 
effect (Clark, J.M. 2007).  The permanently unphosphorylated form of CaV2.2 (T422A), 
unlike the wild-type and T422E channels, displayed a significant decrease in peak current 
in the presence of both the deltamethrin stereoisomers (Symington, S.B. 2007a).  Since 
1R-deltamethrin was ~20-fold more potent on T422E CaV2.2 compared to wild-type, 
T422 CaV2.2, the permanently phosphorylated form of CaV2.2 is assumed to be the 
preferred target of deltamethrin.  This contention is further supported by the observation 
that protein phosphorylation patterns in synaptosomal preparations are modified by 
deltamethrin, possibly by a Ca2+/diacylglycerol-dependent protein kinase (PKC)-
dependent pathway (PKC is the protein kinase that phosphorylates the T422 residue in 
CaV2.2) (Matsumura, F. 1989; Zamponi, G.W. 1997; Enan, E. 1991; Clark, J.M 2008).  
Thus, the differences in the action of deltamethrin on the functional synaptosomal 
preparations versus the heterologously expressed CaV2.2 suggest that other regulatory 
components modulating Ca2+ influx, including channel phosphorylation, may be 
necessary to elicit an in vivo neurotoxic response (Symington, S.B. 2007a; Catterall, 
W.A. 1997; Catterall, W.A. 1998).   
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With respect to pyrethroids presenting a cumulative risk, it was shown that certain 
binary mixtures of pyrethroids at their respective EC50s (equipotent binary mixtures) 
resulted in a more-than-additive effect on neurotransmitter release that was not Ca2+ 
dependent (did not further modify VGCCs) (Table 1) (Frisbie, R.K. 2006).  These 
mixtures included deltamethrin in binary combinations with S-bioallethrin, β-cyfluthrin, 
cypermethrin, or fenpropathrin.  This subgroup of pyrethroids does not fit cleanly into 
either the neurotoxic syndrome (T- or CS- syndrome) or structural (Type I or II) 
classifications.  For example, fenpropathrin, a type II pyrethroid, elicits the T-syndrome. 
This subset of pyrethroids, however, has been identified as calcium-independent VGClC 
antagonists¸ implicating the importance of possible modification of VGClCs in the 
neurotoxicological response of pyrethroids in mammals (Burr, S.A. 2004). 
Originally, Forshaw et al. suggested that VGClCs were target sites for certain 
pyrethroids using patch clamp electrophysiology.  In mouse N1E-115 neuroblastoma 
cells, low concentrations of 1R-deltamethrin, but not cismethrin, decreased the open 
channel probability of voltage-gated maxi chloride channels.  The deltamethrin effect 
could be abolished with the addition of the chloride channel agonist pentobarbitone 
(synonym: pentobarbital).  It was also found that pentobarbitone was effective at 
reducing motor signs in rats caused by deltamethrin, but not the motor signs caused by 
cismethrin (Forshaw, P.J. 1993; Forshaw, P.J. 2000).  The authors speculated that the CS-
syndrome produced by certain pyrethroids may be due to their antagonizing actions at 
VGClCs.     
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Table 1: Relationship of pyrethroids in binary mixtures on calcium influx and endogenous 
L-glutamate released from rat brain synaptosomes. 
Functional Assay Resultsa 
Binary Mixtures 
Calcium Influx L-glutamate Release 
α-Cyano + α-Cyano   
Deltamethrinb,c + λ-Cyhalothrinb Additive Less-than-additive 
Deltamethrin b,c  + γ-Cyhalothrinb Additive Additive 
Deltamethrin b,c + Cypermethrinb,c Additive More-than-additive 
Deltamethrin b,c  + Esfenvalerateb Additive Additive 
Deltamethrin b,c  + Fenpropathrinc Less-than-additive More-than-additive 
Deltamethrin b,c  + β-Cyfluthrinb,c - More-than-additive 
 
α-Cyano + non-Cyano 
  
Deltamethrin b,c  + S-Bioallethrinc Less-than-additive More-than-additive 
Deltamethrin b,c  + Permethrinb Additive Additive 
Deltamethrin b,c  + Tefluthrin Less-than-additive Additive 
 
non-Cyano + non-Cyano 
  
Permethrinb + S-Bioallethrinc Less-than-Additive Additive 
 
a
 Indicates the functional relationship between pyrethroid binary mixtures determined 
using the % additivity equation. 
b Pyrethroids in bold act as VGCC agonists. 
c
 Pyrethroids in italics act as VGClC antagonists as determined by Burr and Ray (Burr, 
S.A. 2004). 
 
 
 
 
   10 
          
Burr et al. subsequently showed (Table 2) that bioallethrin (T-syndrome, type I), 
β-cyfluthrin (CS-syndrome, type II), cypermethrin (CS-syndrome, type II), deltamethrin 
(CS-syndrome, type II), and fenpropathrin (T-syndrome, type II), significantly decreased 
open channel probability.  Bifenthrin (T-syndrome, type I), bioresmethrin (T-syndrome, 
type I), cispermethrin (T-syndrome, type I), cisresmethrin (syndrome not classified, type 
I), cyfluthrin isomers 2 and 4 (T-syndrome, type I), λ-cyhalothrin (CS-syndrome, type II), 
esfenvalerate (CS-syndrome, type II), and tefluthrin (T-syndrome, type I) did not 
significantly alter open channel probability.  Since esfenvalerate and λ-cyhalothrin were 
both α-cyano and CS-syndrome pyrethroids and ineffective in decreasing open channel 
probability, while fenpropathrin and bioallethrin, both T-syndrome and type II and I 
pyrethroids, respectively, it was concluded that actions at the VGClC could not alone 
account for the differences between the two types of poisoning syndromes and that there 
were likely additional sites of action regulating the neurotoxicological response (Burr, 
S.A. 2004).  Table 2 summarizes the effects of Type I and II pyrethroids on decreasing 
open channel probability of voltage-gated maxi chloride channels in excised inside-out 
membrane patches from N1E-115 mouse neuroblastoma cells.  Pyrethroids were 
considered to decrease the open channel probability of chloride channels if the open 
channel probability significantly decreased post-dose as compared to pre-dose (Burr, S.A. 
2004). 
The GABA receptor-ionophore complex has likewise been implicated as a 
molecular target contributing to the neurotoxicity of pyrethroids.  Casida et al. initially 
determined that certain pyrethroids also exhibit stereospecificity at the GABA chloride 
channel (Casida, J.E. 1985; Lawrence, L.J. 1983).  In radioligand [35S] t-  
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Table 2:  Comparison of type I and II pyrethroids on their effect of open channel 
probability in voltage-gated maxi chloride channels. 
Pyrethroid      
(10 µM) 
Type of 
Pyrethroid 
Syndrome 
Elicited 
Decreased Open 
Channel Probability      
(P < 0.05) 
Deltamethrin IIa,b,c,d CSe Yes 
Cypermethrin IIa,b,c CSc Yes 
Fenpropathrin IIa,d Tf Yes 
β-cyfluthrin IIb,d CSb Yes 
Bioallethrin Ia,b Tf,g Yes 
Bifenthrin Ib Not Classifiedb No 
Cisresmethrin Ia Not Classified No 
Cyfluthrin isomer 2 II CSh No 
Esfenvalerate IIa,c,d CSc,g No 
Cyfluthrin isomer 4 II CSh No 
Tefluthrin I Th No 
λ-cyhalothrin IIb,d Th No 
Bioresmethrin Ic Tc No 
Cispermethrin Ia,c T No 
Note.  Pyrethroids are ordered according to the significance of their effect as determined by their P value 
(Burr, S.A. 2004).  
a 
 (Gammon, D.W. 1982) 
b  (Soderlund, D.M. 2002) 
c 
 (Verschoyle, R.D. 1980) 
d  (Wright, C.D.P. 1988) 
e  (Barnes, J.M. 1974)  
f  (Lawrence,  L.J. 1982) 
g  (Verschoyle, R.D. 1972) 
h  (Symington, S.B. 2005) 
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butylbicyclophosphorothionate ([35S]TBPS) binding studies using rat brain synaptic 
membranes, only type II pyrethroids inhibited binding in a stereospecific manner by 
binding to a site closely associated with that of TBPS and picrotoxin (both 
noncompetitive GABAA receptor antagonists) within the chloride channel ionophore.  
They determined that the toxic isomers of cypermethrin, deltamethrin, and fenpropathrin 
(type II - cyanophenoxybenzyl esters), each at 5 µM, inhibited [35S]TBPS binding, 
whereas pyrethroids (up to 10 µM)  that lacked the α-cyano substituent, such as S-
bioallethrin, did not inhibit [35S]TBPS binding.  Since no nontoxic stereoisomers 
inhibited [35S]TBPS binding, it was suggested that the binding site in the receptor was 
stereospecific to the chiral center found in toxic pyrethroids (Lawrence, L.J. 1983).  It has 
been shown subsequently that GABA receptor blockade is not nearly as sensitive to 
pyrethroids as are VGSCs that are assayed in the same preparation.   Nevertheless, the 
potential contribution of GABA receptors to the cumulative risk of pyrethroids cannot be 
discredited (Soderlund, D.M. 2002).     
Hossain et al. recently revealed that certain pyrethroids had differential effects on 
glutamatergic (excitatory) and GABAergic (inhibitory) neurons in the hippocampus of 
rats (Hossain, M.M. 2008).   
Allethrin (type I) exhibited a dual effect where low doses resulted in an increase 
in L-glutamate release but high doses of the compound decreased L-glutamate release.  
Type II pyrethroids, cyhalothrin and deltamethrin, produced opposite effects.  
Cyhalothrin inhibited L-glutamate release while deltamethrin increased L-glutamate 
release, but in a dose-dependent manner.   
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When GABAergic neurons were examined, extracellular levels of GABA 
increased in the presence of allethrin at its high dose and cyhalothrin at all doses, but 
decreased in the presence of deltamethrin.  Interestingly, tetrodotoxin (TTX), a sodium 
channel blocker, prevented the effect of allethrin and cyhalothrin at all doses on L-
glutamate and GABA release, but only partially blocked the effects of the highest dose of 
deltamethrin on L-glutamate release.  These findings suggested that the effect of 
deltamethrin on L-glutamate release was not completely sodium-dependent and that 
additional mechanisms of action at other ion channels may be responsible.  Local 
infusion of the L-type calcium channel blocker, nimodipine, completely blocked 
deltamethrin-evoked L-glutamate release at its highest concentration. These data 
collectively suggest that the excitatory glutamatergic neurons in the hippocampus are 
modulated by inhibitory GABA-releasing interneurons and confirm previous findings 
that multiple mechanisms are likely involved with the neurotoxic action of pyrethroids 
(Hossain, M.M. 2008).   
In summary, certain binary mixtures of pyrethroids produce a more-than-additive 
effect on L-glutamate release at presynaptic nerve terminals that is not calcium-
dependent.   In a separate study, all pyrethroids in the four more-than-additive binary 
mixtures were also found to decrease the open channel probability of VGClCs, 
suggesting that these channels may play a role in the more-than-additive response 
previously observed in rat brain synaptosomes.  In addition, pyrethroids exhibit 
stereospecificity at a binding site within the GABA chloride channel, the major regulator 
of inhibitory neurotransmitter release, further establishing the role of chloride channels in 
pyrethroid neurotoxicity.  Thus, we hypothesize that an additional action at chloride 
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channels may be responsible for the more-than-additive effect on L-glutamate release 
previously seen with the equipotent binary mixtures of pyrethroids (deltamethrin with S-
bioallethrin, β-cyfluthrin, cypermethrin, and fenpropathrin).  To test this hypothesis, 
specific chloride channel blockers (antagonists) in the presence of deltamethrin were 
expected to reproduce the more-than-additive response. 
Synaptosomes are an ideal in vitro model system to use to study the effects of 
pyrethroids since many of the physiological characteristics of the intact presynaptic nerve 
terminal are retained including: K+ -stimulated Ca2+ influx and subsequent Ca2+ -
dependent endogenous neurotransmitter release (L-glutamate) (Symington, S.B. 2007b).  
Additionally, synaptosomes are easily prepared, applicable to a variety of physiological 
measurements using fluorescent spectrophotometry, and are fully functional for a period 
of a few hours after preparation. 
Since chloride channels generally function as rectifying channels to stabilize the 
membrane potential (Clark, J.M. 1995), it is expected that blocking these channels in the 
presynaptic nerve terminal, will increase neurotransmitter release.  Furthermore, since 
deltamethrin targets VGSCs, VGCCs, and VGClCs (Burr, S.A. 2004), it is expected that 
deltamethrin at its EC50 value in the presence of a chloride channel antagonist will 
reproduce the more-than-additive effect.  Lastly, concentrations of the four binary 
mixtures of pyrethroids that produced more-than-additive effects on L-glutamate release 
(Frisbie, R.K. 2006) should be shifted to lower concentrations in the presence of a 
chloride channel antagonist.  In the presence of a chloride channel agonist, the more-
than-additive response should be shifted to higher concentrations. 
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Antagonists and agonists were chosen based on their specificity to the many 
different types of chloride channels found in presynaptic nerve terminals.   Anthracene-9-
carboxylic acid (9-AC) and rChlorotoxin (ClTx) are VGClC and calcium-activated 
chloride channel (CaClC) antagonists. 4,4' - dinitrostilbene - 2,2' - disulfonic acid  
(DNDS) is a volume-regulated anion channel (VRAC) antagonist and 5-nitro-2-(3-
phenylpropylamino) benzoic acid (NPPB) is a VGClC, CaClC, and VRAC antagonist.  
Picrotoxinin is an antagonist of the GABA-gated chloride channel while pentobarbital 
and muscimol are GABA-gated
 
chloride channel agonists.   
Because there may be significant aspects of pyrethroid toxicity that were not 
considered in their original evaluations, findings from these experiments are expected to 
provide valuable insight into the assessment of the cumulative risk of pyrethroids and 
therefore their regulation under the FQPA.   
 
1.2  Voltage-Gated Calcium Channels 
 
Of the many channels and pumps that control intracellular calcium levels, 
voltage-gated calcium channels (VGCCs) play a key role in calcium homeostasis (Perez-
Reyes, E. 2003).  Depolarization-mediated calcium influx through VGCCs elicits a wide 
range of cytoplasmic responses that includes contraction of cardiac muscle, cellular 
proliferation, activation of calcium-dependent enzymes, and the release of hormones and 
neurotransmitter molecules (Wheeler, D.B. 1994; Tedford, H.W. 2006; Evans, R.M. 
2006).  Several subtypes of VGCCs have been identified based on their pharmacological 
and electrophysiological properties (termed L-, N- P-, Q-, R-, or T-types) with the 
predominant diversity lying within the pore-forming α1 subunit (Evans, R.M. 2006).   
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Although each subtype functions to allow the passage of calcium ions into 
excitable cells, they differ in their cellular expression pattern, subcellular distribution, and 
the cytoplasmic messenger molecules that regulate them (e.g. protein kinases and G 
proteins) (Jarvis, S.E. 2001; Tedford, H.W. 2006).  Calcium not only functions as a 
second messenger, but its entry into the cell can cause depolarization and activate other 
voltage-gated ion channels associated with the plasma membrane (Perez-Reyes, E. 2003).  
Calcium entry into these cells is therefore carefully regulated since excessive amounts of 
intracellular calcium are not only potentially toxic to the cell, but have also been linked to 
several disorders, and mutations and deletions in voltage-gated calcium channel genes 
have been associated with migraines, cerebellar ataxia, night blindness, and epilepsy 
(Jarvis, S.E. 2001; Lorenzon, N.M. 2000).   
There are three families of VGCCs classified by the α1 subunit gene subfamily (1-
3).  Calcium channels were named using the chemical symbol of calcium (Ca) with the 
principal physiological regulator of this channel (voltage) indicated as a subscript (CaV) 
(Catterall, W.A. 2003).  Cav1 genes encode L-type channels, Cav2 genes encode N-type, 
P/Q type, and R-type channels, and Cav3 genes encode T-type channels (Evans, R.M. 
2006).  Table 3 summarizes the physiological function and pharmacology of VGCCs.  
For the purposes of this study, we focus on the Cav2 family of VGCCs, which are 
responsible for calcium entry into neurons and for calcium-mediated neurotransmitter 
release from presynaptic nerve terminals (Tedford, H.W. 2006).   
 The Cav2 subfamily (Cav2.1-3) includes channels containing α1A, α1B, and α1E 
subunits, which allow P/Q-, N-, and R-type calcium currents, respectively.  Alternative 
splicing of the Cav2.1 gene gives rise to the P- and Q-type channels (Catterall, W.A. 
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2000; Evans, R.M. 2006).  Together the P/Q-type and N-type channels largely account 
for the rapid release of synaptic vesicles at the presynaptic nerve terminal following 
depolarization and calcium influx.  The overall contribution of each, however, varies with 
the neuronal preparation (Burke, S.P. 1993; Potier, B. 1993; Tedford, H.W. 2006).  The 
role of R-type channels is less well understood.  They are localized to proximal dendrites 
and presynaptic nerve terminals, and thought to also contribute to the synaptic release of 
neurotransmitters (Tedford, H.W. 2006; Evans, R.M. 2006). 
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Table 3: Voltage-gated calcium channel subunit compositions and functions (adapted from 
Catterall 2003). 
Ca2+ Channels Ca
2+
 Current 
type 
Primary 
Localizations 
Cellular 
Functions 
CaV1.1 L Skeletal muscle Excitation-contraction coupling 
Calcium homeostasis 
Gene regulation 
CaV1.2 L Cardiac muscle 
Endocrine cells 
Neurons 
Excitation-contraction coupling 
Hormone secretion 
Gene regulation 
CaV1.3 L Endocrine cells 
Neurons 
Hormone secretion 
Gene regulation 
CaV1.4 L Retina Tonic neurotransmitter release 
CaV2.1 P/Q Nerve terminals 
Dendrites 
Neurotransmitter release 
Dendritic Ca2+ transients 
CaV2.2 N Nerve terminals 
Dendrites 
Neurotransmitter release 
Dendritic Ca2+ transients 
CaV2.3 R Cell bodies 
Dendrites 
Nerve terminals 
Ca2+ -dependent action potentials 
Neurotransmitter release 
Repetitive firing 
CaV3.1 T Cardiac muscle 
Skeletal muscle 
Neurons 
Repetitive firing 
CaV3.2 T Cardiac muscle 
Neurons 
Repetitive firing 
CaV3.3 T Neurons Repetitive firing 
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1.3  Chloride Channels 
 
 
Since the cloning and functional expression of the first member of the mammalian 
voltage-dependent chloride channel (CLC) family of chloride channels in 1990 by 
Jentsch et al, chloride channels have become one of the most exciting topics in channel 
research.  It is now well established that these channels function in several critical 
processes, including cell cycle and apoptosis, volume regulation, synaptic transmission, 
and cellular excitability (Nilius, B. 2003).  Chloride channels are classified according to 
their mechanism of activation, and depends on: 1) transmembrane voltage (voltage-
gated/dependent/sensitive channels, the ClC family), 2) cell swelling (volume-regulated 
anion channels, VRAC), 3) the binding of signaling molecules (ligand-gated anion 
channels of presynaptic and postsynaptic membranes, such as glycine- or γ-aminobutyric 
acid (GABA)- activated chloride channels, GABAClC), 4) the phosphorylation of 
intracellular serine or threonine residues by protein kinases (cystic fibrosis 
transmembrane conductance regulator, CFTR), and 5) various ions (e.g., anions, H+ (pH), 
or Ca2+ (Ca2+- activated chloride channels, CaClC)) (Jentsch, T.J. 2002; Nilius, B. 2003).  
This classification scheme is not perfect, however, as some mechanisms of activation 
overlap (e.g. volume-regulated channels may also be voltage-dependent).  It is likely that 
the final classification will be based on structural classes once more is learned about the 
structural similarities amongst channels (Jentsch, T.J. 1997).   
There are currently three well-established gene families of chloride channels.  In 
mammals, these include the largest known family, the ligand-gated GABA and glycine-
receptor chloride channels, the CFTR family, and the CLC family (Jentsch, T.J. 1997).  
The plasma membrane of presynaptic nerve terminals possess ClCs, GABA/glycine-
   20 
          
gated chloride channels, and the less well understood CaClCs (Meir, A. 1999) and hence 
were the focus of this investigation. 
The CLC has nine different genes in mammals that can be grouped into three 
clades based on sequence homology (Fig. 2) (Jentsch, T.J. 1993).  The first clade 
comprises plasma membrane channels ClC-1, ClC-2, ClC-Ka, and ClC-Kb, which are 
close homologues of the prototype Torpedo marmorata channel ClC-0 and are involved 
in the stabilization of membrane potential and transepithelial transport.  Members of the 
other two clades reside in intracellular membranes and have been implicated in the 
acidification of intracellular compartments such as endosomes and lysosomes.  These 
include ClC-3, ClC-4, and ClC-5, and ClC-6 and ClC-7, respectively (Pusch, M. 2006; 
Jentsch, T.J. 2005).   
Although most channel proteins in the CLC family show voltage-dependent 
gating, ClC-2 channels are highly expressed in specific regions of the brain and are 
activated by hyperpolarized potentials, cell swelling, and acidic pH, all important features 
of neuronal excitability (Thiemann, A. 1992; Grunder, S. 1992; Jordt, S.E. 1997). 
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Expression Function
Skeletal muscle
Broad
Kidney, inner ear
Kidney, inner ear
Broad
(brain, kidney, liver…)
Broad (brain, muscle…)
Kidney (intestine, liver…)
Broad
Broad
Stabilization of plasma membrane V
Transepithelial transport?
pH, volume regulation
Transepithelial transport
Transepithelial transport
Acidification of endosomes, synaptic 
vesicles
?
?
Acidification of endosomes
Acidification of lysosomes, resorption
lacuna of osteoclasts.
ClC-0
ClC-1
ClC-2
ClC-Ka
ClC-Kb
ClC-3
ClC-4
ClC-5
ClC-6
ClC-7
 
Figure 2:  The ClC family of chloride channels in mammals.  The dendogram denotes the 
similarity between the different genes.  Distribution of genes in tissue and suggested 
functions are indicated.  Adapted from (Jentsch, T.J. 1997).   
 
 
 
The ligand-gated ion channel (LGIC) superfamily also known as ionotropic 
receptors, are regulated by the binding of chemical messengers, as opposed to the 
voltage- or stretch-activated channels.  The LGIC superfamily is comprised of γ-
aminobutyric acid (GABA), glycine (GlyR), nicotinic acetylcholine (nAChR), and the 5-
hydroxytryptamine type 3 (5-HT3) receptors (Betz, H. 1990; Macdonald, R.L. 1994; 
Kash, T.L. 2004).   
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In the central nervous system (CNS), GABA modulates inhibitory synaptic 
transmission by activating three classes of receptors: GABAA, GABAB, and GABAC 
receptors.  Of these, GABAA and GABAC belong to the LGIC family.  GABAB receptors 
belong to the G protein-coupled receptors (metabotropic receptors) (Meir, A. 1999).  The 
binding of GABA to the extracellular domain (ECD) causes a rapid allosteric transition in 
the ion-conducting pore within the transmembrane domain (TMD) (Chakrapani, S. 2004).  
The resulting chloride influx hyperpolarizes the neuron and inhibits neuronal activity 
(Jentsch, T.J. 2002).   
Chloride currents that are mediated by cytosolic calcium levels are termed 
calcium-dependent or calcium-activated chloride channels (also known as CaCC, CaClC 
or (Cl)Ca) (Hartzell, C. 2005).  CaClCs have been identified in many cell types, including 
epithelial cells, neurons, cardiac and smooth muscle cells, and blood cells (Eggermont, J. 
2004; Hartzell, C. 2005).  Likewise, they have been implicated in a variety of cellular 
functions that include fertilization of oocytes, transepithelial fluid transport, and 
membrane excitability in cardiac muscle and neurons (Hartzell, C. 2005).  Although their 
functions in neurons remain poorly established, it is thought that they are involved in 
membrane repolarization, the generation of after-potentials, and membrane oscillatory 
behavior (Hartzell, C. 2005).  In most cells, the resting membrane potential is more 
negative than the chloride equilibrium potential, so when intracellular calcium, ([Ca2+]i), 
rises, chloride is effluxed from the cell causing a depolarization (Hartzell, C. 2005) and it 
is thought that CaClC-induced depolarization may also activate VGCCs (Nilius, B. 
2003).  Alternatively, if the chloride equilibrium potential is below the membrane 
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potential, then opening of CaClCs can lead to hyperpolarization as chloride fluxes in 
(Hartzell, C. 2005).   
As their name implies, activation of CaClCs requires a rise in [Ca2+]i, which can 
come from either intracellular stores or influx of extracellular calcium (Hartzell, C. 
2005).  In some cases, calcium channels are coupled to CaClCs, such as in mouse 
sympathetic neurons, where L- and P-type VGCCs activate CaClCs (Martinez-Pinna, J. 
2000).  CaClC activation by calcium occurs via two general mechanisms: calcium can 
either bind to the channel protein directly or act indirectly on the channel via Ca2+-
binding proteins (e.g. calmodulin) or Ca2+-dependent enzymes (e.g. calmodulin-
dependent protein kinase of CamKII)  (Hartzell, C. 2005).   
 
 
1.4 Pharmacology of Chloride Channels 
 
 
Ion channel modulators have important medical ramifications.  Additionally, they 
are also widely used to isolate ion channel proteins, to distinguish between gating states, 
to investigate pore structure, and more commonly, to selectively suppress or enhance one 
type of ion channel out of a mixture of currents.  Unfortunately, this is often difficult to 
do with anion channel modulators due to their inability to completely suppress ion flux.  
Because of their low potency, the high concentrations utilized generally result in 
undesirable side effects on ion transporters and components of intracellular signaling 
pathways.  Lastly, many anion channel blockers lack selectivity making interpretations 
from pharmacological studies more complicated (Jentsch, T.J. 2002; Hartzell, C. 2005).   
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Table 4 provides the pharmacology profiles of the mammalian neuronal chloride 
channels examined in this study.  As mentioned previously, many chloride channels 
overlap in their mechanisms of activation, and are likewise affected by a variety of 
nonspecific modulators.   
 
Table 4. Pharmacology of mammalian chloride channels in nerve preparations. 
Inhibitor Type Inhibitor ClC-2 CaCC VRAC GABAA ClC 
Anthracene carboxylates 9-AC √a,b √d   
Arylaminobenzoates NPPB √a,b,c √e,f √g  
Disulfonic stilbene  DNDS   √g  
Protein toxin ClTx √c √f   
Polycyclic epoxylactone PTX    √h 
a
 (Furukawa, T. 1998) 
b  (Clark, S. 1998) 
c  (Thompson, C.H. 2005) 
d  (De Castro, F. 1997) 
e  (Hartzell, C. 2005) 
f
  (Dalton, S. 2003) 
g  (Abdullaev, I.F. 2006) 
h
 (Zhang, S.J. 1993) 
 
 
 
1.5 Role of Chloride Channels in Neurotransmitter Release 
 
 
Chloride is the most abundant extracellular physiological anion in animal cells 
and plays a major role in stabilizing the membrane potential of excitable cells.  In nerve 
terminals, this stabilizing function of chloride channels is involved with the inhibition of 
neurotransmitter release (Meir, A. 1999).   Since the concentration of chloride in the 
cytoplasm is lower than outside of the cell, the chloride equilibrium potential (ECl) is 
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generally close to the resting membrane potential (Grunder, S. 1992; Smith, R.L. 1995; 
Meir, A. 1999).   
Upon excitation of the membrane by depolarization due to sodium and/or calcium 
influx, chloride channels oppose neuronal excitability by rectifying or repolarizing the 
membrane potential by fluxing chloride ions into the cell, thus preventing the further 
release of neurotransmitters (Hille, B. 2001; Suzuki, M. 2006).  VGClCs are largely 
responsible for rectifying the excitable membrane potential.  ClC-2 in particular are 
activated by hyperpolarization, deactivated by depolarization, and show no time-
dependent inactivation (Staley, K. 1994; Smith, R.L. 1995). 
Fast inhibitory neurotransmission in the mammalian nervous system is mediated 
by the neurotransmitter GABA.  In presynaptic nerve terminals, GABA-mediated 
chloride current is believed to inhibit neurotransmitter release via two mechanisms.  The 
first is by retardation in the propagation of action potentials onto the nerve terminal, and 
second, by a decrease in the amount of neurotransmitter released by each action potential 
that reaches the terminal. This inhibition occurs by shunting membrane currents and 
reducing the probability of other ion channels (sodium and calcium) opening (Jackson, 
M.B. 1995; Meir, A. 1999).  Another mechanism by which chloride channels regulate 
presynaptic inhibition has been proposed by a mathematical model that suggests 
depolarization, in association with an increase in outward chloride conductance, may 
inactivate other ion channels in the nerve terminal such as calcium and sodium channels 
(Graham, B. 1994). 
CaClCs have also been implicated in the regulation of neurotransmitter release.  
Although CaClCs are expressed in a variety of different neurons, their functions remain 
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poorly established (Hartzell, C. 2005).  Thus far, it is believed that CaClCs modulate 
excitability by generating afterpotentials, which in some neurons, may be sufficient to 
trigger spontaneous firing.  It has been established that there are three factors that dictate 
the direction of chloride through CaClCs: the membrane potential, chloride concentration 
gradient, and the intracellular calcium concentration. When intracellular calcium 
increases either due to release from intracellular stores or influx via VGCCs, CaClCs are 
activated and cause chloride to exit the cell, resulting in a depolarization.  This 
depolarization can increase the open channel probability of VGCCs resulting in 
additional calcium influx, thus further enhancing the depolarization, and ultimately 
neurotransmitter release.  CaClCs can also lead to hyperpolarization when the membrane 
potential is more positive than the ECl (Hartzell, C. 2005).  See section 1.7 for regulation 
of chloride channels. 
 
 
1.6 Regulation of Chloride Channels 
 
 
Given the ubiquitous expression and numerous physiological functions that 
chloride channels possess, it is no surprise that they are likewise regulated or activated by 
many mechanisms.  As previously mentioned in section 1.3, chloride channels are 
classified according to their mechanism of activation.  For the purposes of this study, the 
mechanisms of activation for ClC-2, GABA ClCs, and CaClCs found in presynaptic 
nerve terminals will be discussed. 
ClC-2 belong to the family of voltage-gated chloride channels.  Since many 
VGClCs function to rectify the membrane potential, the intracellular concentration of 
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chloride is always lower than the extracellular concentration and ECl is still above the 
resting membrane potential (RMP) (Hille, B. 2001).  These channels would be expected, 
when activated by hyperpolarization, to be inwardly rectifying with significant 
conductance (GCl(v)) only at membrane potentials more negative than ECl, ultimately 
repolarizing the cell during an action potential and reducing excitability (Staley, K. 1994; 
Smith, R.L. 1995).  In nerve terminals, the activation of VGClCs is associated with 
presynaptic inhibition since the decreased efficiency of subsequent inward currents to 
produce a depolarization reduces neurotransmitter release (Rudomin, P. 1990; Meir, A. 
1999).  It was determined that ClC-2 cDNA cloned from rat brain and heterologously 
expressed in Xenopus laevis oocytes displayed a similar voltage dependence to GCl(v) and 
that both ClC-2 and GCl(v) slowly activate at hyperpolarized potentials (-90 mV), 
deactivate at depolarized potentials (-30 mV), and show no time-dependent inactivation 
(Thiemann, A. 1992; Grunder, S. 1992; Staley, K. 1994). 
Phosphorylation of ClC-2 channels suggests another possible mechanism by 
which these channels are regulated.  One group showed that PKA was able to 
phosphorylate ClC-2 in vivo and in vitro, but when heterologously expressed in Xenopus, 
they found that the current was not affected (Park, K. 2001).  To determine if PKA was 
directly phosphorylating ClC-2 or doing so by acting through another kinase, PKC and 
CaMKII were examined for their ability to phosphorylate ClC-2.  Their findings revealed 
that PKC (in vivo and in vitro) and CaMKII (in vitro) failed to phosphorylate ClC-2.  
Though these results suggest that PKA activation of rat ClC-2 in vivo is independent of 
chloride channel activity, the possibility that PKC or CamKII activation might indirectly 
regulate ClC-2 activity cannot be ruled out (Park, K. 2001).  A mechanism by which PKC 
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may indirectly modulate ClC-2 activity is described by Hartzell et al. where an increase 
in intracellular calcium due to IP3 activates CaClCs, which produces a depolarization and 
ultimately feeds back to open additional ClC-2 (Hartzell, C. 2005).  Indirect 
phosphorylation of ClC-2 by CaMKII has not been elucidated in rat neuron preparations, 
but has been in other species and preparations (Hartzell, C. 2005).  In another study, 
researchers showed that rat ClC-2 lacked consensus sites for cAMP-dependent 
phosphorylation, but rabbit and human ClC-2 (at different positions) had them (Jordt, 
S.E. 1997).  Together, these findings suggest that regulation of ClC-2 may be cell-type or 
species-specific. 
ClC-2 channels may also function to prevent excessive osmotic swelling.  When 
cells are exposed to hypotonic solutions or intracellular hypertonic solutions, they begin 
to swell and then recover their normal volume by releasing enough salt to prevent further 
water entry (Hille, B. 2001; Grunder, S. 1992; Nilius, B. 1996).  It is said that during cell 
swelling, depolarization due to the activation of this channel may also trigger exocytosis 
in cells that possess L-type calcium channels (Grunder, S. 1992).  However, these events 
are likely not relevant to pyrethroid neurotoxicity since membrane depolarization and 
increased neurotransmitter release from isolated presynaptic nerve terminals is observed 
when these channels are blocked.  The regulation of these channels by volume will 
therefore not be further discussed.   
It has been shown that the voltage-dependent current via ClC-2 is enhanced at 
normal resting potentials by low extracellular pH (Jordt, S.E. 1997; Park, K. 2001).  Also, 
a deceleration in exocytosis was observed when chloride entry into chromaffin granules 
was inhibited by NPPB, thereby impairing the acidification of the granule (Camacho, M. 
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2006).  Since neither of these events are consistent with previous findings that suggest 
inhibition of chloride channels results in an increase in L-glutamate release from isolated 
presynaptic nerve terminals, the regulation of ClC-2 by pH will not be discussed further 
for its role in pyrethroid neurotoxicity and neurotransmission.   
The GABA receptor chloride ionophore (GABAAClC) is a ligand-gated ion 
channel superfamily, is responsible for fast inhibitory neurotransmission in the 
mammalian nervous system.  Binding leads to the opening of the chloride channel within 
the complex and chloride influx, ultimately hyperpolarizing the neuron and thereby 
inhibiting neuronal activity (Meir, A. 1999; Jentsch, T.J. 2002).  It is also thought that 
activation of ClC-2 may help the ligand-gated chloride channels to yield hyperpolarizing 
currents since ClC-2 activity determines intracellular Na+ and Cl- concentration 
(Dinudom, A. 1993; Suzuki, M. 2006).   
GABAA receptors are also modulated by phosphorylation.  Porter et al. found that 
the GABAA receptor contains a consensus phosphorylation site on an intracellular 
domain of the channel for cAMP-dependent protein kinase (PKA).  Using whole-cell and 
excised, outside out patch clamp on cultured mouse spinal neurons, PKA significantly 
reduced GABA-evoked chloride currents by reducing the channel opening frequency and 
they speculate that a reduction in receptor function may lead to increased neuronal 
excitability (Porter, N.M. 1990).  These findings are consistent with previous studies on 
rat brain synaptoneurosomes where cAMP (an activator of PKA) decreased GABAA 
receptor-mediated chloride flux (Heuschneider, G. 1989).   
Browning et al. determined that Ca2+/phosphatidylserine-dependent protein kinase 
(PKC) and PKA also phosphorylate the GABAA receptor purified from rat brain, but 
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Ca2+/calmodulin kinase II (CaM kinase II) does not (Browning, M.D. 1990).  Shortly 
after these findings, another group found that the PKC activator, phorbol myristoyl 
acetate (PMA), but not the inactive analog, phorbol 12-mono-myristate (PMM), inhibited 
GABA-gated chloride currents in Xenopus oocytes expressing mouse brain mRNA 
(Leidenheimer, N.J. 1992).  They also found that PMA inhibited GABA-gated chloride 
currents from GABAA receptors in oocytes coexpressing human α1β1γ2L subunit cDNAs.  
In mouse brain microsacs, activators of PKC as well as inhibitors of protein 
phosphatases, reduced muscimol-stimulated 36Cl- uptake by brain membrane vesicles 
(Leidenheimer, N.J. 1992).  In all, these findings provide evidence that the function of 
GABAA receptors in situ can be inhibited by PKC phosphorylation.   
 CaClC activation requires a rise in intracellular calcium concentration ([Ca2+]i) 
which can come from calcium influx or calcium release from intracellular stores.  When 
([Ca2+]i is below ~1 µM, calcium-activated chloride current (ICl,Ca) is both voltage and 
time dependent, however, when ([Ca2+]i rises above ~1 µM, the voltage and time 
dependence disappears as the activation rate increases.  Deactivation of CaClCs follows a 
time course that is voltage dependent (Hartzell, C. 2005).   
Calcium can directly activate CaClCs by binding to the channel or indirectly 
activate the channel by interacting with calcium-binding proteins or calcium-dependent 
enzymes (Hartzell, C. 2005).  One study using Xenopus oocytes injected with rat brain 
mRNA, showed that L-glutamate receptors indirectly regulated calcium-dependent 
chloride channels via an inositol 1,4,5-triphosphate (IP3)-Ca2+ pathway.  When L-
glutamate was applied to the bath, whole-cell currents were evoked and reversed 
direction near the chloride equilibrium potential.  Likewise, injection of IP3 or calcium 
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into the oocyte caused an increase in intracellular free calcium regardless of extracellular 
calcium and the subsequent current exhibited a reversal potential near the chloride 
equilibrium potential.  These results suggested that glutamate receptors activate 
endogenous chloride channels utilizing IP3 which mobilizes the calcium in the cell that 
activates CaClCs (Oosawa, Y. 1989). 
 Additional evidence for activation of CaClCs by extracellular calcium was 
demonstrated by Martinez-Pinna et al. when the use of selective VGCC inhibitors 
revealed that L- and P-type VGCCs appear to selectively couple to CaClCs while N-type 
VGCCs couple with calcium-activated potassium channels (Martinez-Pinna, J. 2000; 
Hartzell, C. 2005).     
To our knowledge, direct binding of calcium to CaClCs has not yet been reported 
in neuronal preparations.   
 
 
1.7 Role of Chloride Channels in Pyrethroid Neurotoxicity 
 
 
VGSCs have been well established for decades as a major target site for all 
pyrethroids, however, due to the variablity of pyrethroid structures and/or the bimodal 
effect of pyrethroids on mammals (T- vs CS-syndrome), it was suggested that there was 
either heterogeneity within the sodium channel targets (Soderlund, D.M. 2002) or that 
pyrethoids, specifically the type II pyrethroids, had additional sites of action (Burr, S.A. 
2004).  Among the different sites of action proposed, chloride ion channels are believed 
to contribute significantly to pyrethroid neurotoxicity.  The first interaction of pyrethroids 
on ligand-gated chloride channels was reported by Leeb-Lundberg and Olsen in 1980.  
These findings established a stereospecific inhibition by deltamethrin on the binding of 
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[3H]dihydropicrotoxinin to the convulsant site (chloride channel) of GABA receptors in 
rat brain synaptic membranes (Leeb-Lundberg, F. 1980).  Later Lawrence and Casida 
conducted a study on 37 pyrethroids and documented the inhibition of [35S]TBPS binding 
in rat brain synaptic membranes by the toxic isomers containing the α-cyano moiety, but 
not by the non-toxic isomers of the α-cyano compounds or by any pyrethroids lacking the 
α-cyano moiety (Lawrence, L.J. 1983).  Gammon et al. likewise proposed that ligand-
gated chloride channels were targets in both mouse and cockroach preparations 
(Gammon, D.W. 1982). 
Collectively, these findings led to the hypothesis that type II pyrethroids were 
convulsants and caused the CS-syndrome by blocking GABA binding at the GABA 
receptor-ionophore complex and indirectly augmented the release of excitatory 
neurotransmitters due to the reduced inhibitory input to the nervous system.  Several 
studies of α-cyano pyrethroids inhibiting GABA-stimulated chloride uptake into brain 
vesicles further confirmed these pyrethroids as antagonists at the mamamalian brain 
GABA receptors (Bloomquist, J.R. 1986; Abalis, I.M. 1986).  However, chloride uptake 
was typically incomplete at maximally effective pyrethroid concentrations. In addition, 
electrophysiolgoical assays that assessed the relative sensitivity of GABA receptors and 
VSSCs in dorsal root ganglion neurons found that GABA receptors were much less 
senstive to the actions of deltamethrin than were VSSCs.  In all, these findings indicated 
that the ligand-gated chloride channel was not sufficiently sensitive to pyrethroids to have 
an influence at doses relevant to systemic poisoning.   
Not long after these findings, VGClCs were proposed as targets for pyrethroids 
when it was found that deltamethrin decreased the open channel probability of these 
   33 
          
channels, which was similar to the action of the chloride channel antagonist, 9-AC, in 
excised, inside-out patches of N1E-115 neuroblastoma cells (Forshaw, P.J. 1993).  
Additional studies further confirmed VGClCs as an improtant site of action for certain 
type II pyrethroids in that deltamethrin and cypermethrin (type II pyrethroids) decreased 
the open channel probability of VGClCs, while the type I pyrethroid cismethrin did not 
(Ray, D.E. 1997).   Interestingly, the chloride channel agonist, pentobarbitone, was 
effective against the type II motor signs caused by deltamethrin, but not against the type I 
motor signs produced by cismethrin (Forshaw, P.J. 2000).  Since deltamethrin affected 
VGClCs at concentrations that were toxicologically relevant, it was proposed that type II 
pyrethroids may contribute to the bimodal nature of the pyrethroid poisoning syndromes.  
These effects of pyrethroids on these channels, however, have not been confirmed in 
insect preparations (Bloomquist, J.R. 2003).     
To date, CaClCs have not been implicated in the acute neurotoxic action of 
pyrethroids in either mammalian or insect preparations.  However, the existence of 
pharmacological crosstalk between different chloride channel types complicates the 
pharmacological discrimination between these channels, and thus, they cannot be 
overlooked for their contribution to pyrethroid neurotoxicity (Soderlund, D.M. 2002) 
 
 
 
 
.  
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CHAPTER 2 
 
MATERIALS AND METHODS 
 
 
2.1 Animals 
 
Retired (ex-breeder) female Sprague-Dawley rats (400-600 g and ≥ 8 months) 
were purchased from Charles River Laboratories (Wilmington, MA) and maintained at 
the Central Animal Care Facility, Morrill Science Center 4 South, University of 
Massachusetts-Amherst (Amherst, MA).  Animals were accommodated in standard 
plastic animal cages (45 cm x 24 cm x 20 cm) at two per cage ad libitum, on a 12:12 hr 
day and night light cycle.  Animal procedures were conducted in accordance with the 
Institutional Animal Care and Use Committee (IACUC) guidelines (Protocol #: 26-09-
12).   
 
2.2 Chloride Channel Ligands 
 
Chloride channel blockers (antagonists); anthracene-9-carboxylic acid (9-AC), 
4,4’-dintitrostilbene-2,2’-disulfonic acid (DNDS), 5-nitro-2-(3-phenylpropylamino) 
benzoic acid (NPPB), and picrotoxinin (PTX) were purchased from Sigma-Aldrich Inc. 
(St. Louis, MO) and rChlorotoxin (ClTx) was purchased from Alomone labs (Jerusalem, 
Israel).  Stock solutions of 9-AC, DNDS, and NPPB were made in dimethyl sulfoxide 
(DMSO) with the final serial dilutions in 95 % ethanol.  All PTX stock solutions were 
solubilized in 95% ethanol.  ClTx was made in a conventional buffer of 20 mM HEPES 
   35 
          
(pH 7.0).  New stock solutions were made monthly and stored at -20 oC.  See Appendix A 
for the chemical structures of the chloride channel ligands used in this study.  
 
2.3 Pyrethroids 
 
Technical grade pyrethroids (Table 5) used in this study were provided by the 
Pyrethroid Working Group (PWG); a conglomerate of the major manufacturers of 
synthetic pyrethroids in the United States and United Kingdom that is comprised of 
Aventis CropScience (Dublin, NJ), Bayer Corporation (Kansas City, MO), DuPont 
Agricultural Products (Newark, NJ), FMC Corporation (Philadelphia, PA), Syngenta 
(Cheshire, UK) and Valent USA Corporation (Montvale, CA). 
Pyrethroid stock solutions were prepared in DMSO and serial diluted as required.  
The final serial dilution was made in 95 % ethanol.  Binary mixtures of pyrethroids were 
prepared in equipotent ratios of their respective EC50s the day of experiments unless 
otherwise indicated.  See Appendix B for the chemical structures of the pyrethroids used 
in this study.   
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Table 5. The isomeric composition of the pyrethroids used in this study. 
Compound Name 
(Manufacturer) CAS RN Isomeric Composition 
Cypermethrina (FMC) 
(S)-α-cyano-3-phenoxybenzyl (1R,3R)-3-(2,2-
dichlorovinyl)-2,2-
dimethylcyclopropanecarboxylate 
 
52315-07-8 
98.7%- 
(S)-α-cyano-, (1R)-cis- 
Deltamethrina (Aventis) 
(S)-α-cyano-3-phenoxybenzyl (1R,3R)-3-(2,2-
dibromovinyl)-2,2-
dimethylcyclopropanecarboxylate 
 
52820-00-5 
98.0%- 
(S)-α-cyano-, (1R)-cis- 
Fenpropathrina (Valent) 
(RS)-α-cyano-3-phenoxybenzyl 2,2,3,3-
tetramethylcyclopropanecarboxylate 
 
64257-84-7 
99.7%- 
(RS)-α-cyano- 
Tefluthrina (Syngenta) 
2,3,5,6-tetrafluoro-4-methylbenzyl (Z)-
(1R,3R)-3-(2-chloro-3,3,3-trifluoroprop-1-
enyl)-2,2-dimethylcyclopropanecarboxylate 
 
79538-32-2 
95.0%- 
(Z)-(1R)-cis- 
a
 Structures for pyrethroids used in this study are illustrated in Appendix B. 
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2.4 Chemicals 
 
Percoll™ was purchased from GE Healthcare Bio-Sciences Corporation 
(Piscataway, NJ).  Amplex® UltraRed reagent was purchased from Invitrogen 
Corporation (Carlsbad, California).  All other chemicals and enzymes were purchased 
from Sigma-Aldrich Inc. (St. Louis, MO) at the highest purity available.     
 
2.5 Synaptosome Preparation 
 
Synaptosomes were prepared from whole rat brain sans brain stem as previously 
described (Dunkley et al., 1986) with the following modifications.  Rats were sacrificed 
by decapitation after CO2-induced unconsciousness and whole brains removed.  Brain 
tissue was homogenized using a 15 ml Teflon-glass homogenizer with a motor-driven 
pestle (Model K43, Tri-R Instruments, Rockville Centre, NY) for 4-5 cycles at 400 rpm 
(~2-3 min) in ice-cold sucrose buffer (0.32 M sucrose, 1 mM EDTA, and 5 mM tris-base, 
pH = 7.4) and the homogenate centrifuged at 900 g for 10 min at 4 °C.  The supernatant 
was transferred and divided into two new tubes and centrifuged at 15,000 g for 30 min at 
4 °C.  The resulting crude mitochondrial pellets (P2) were gently resuspended manually 
in saline A buffer (125 mM NaCl, 5 mM KCl, 1.2 mM NaH2PO4, 1.2 mM MgCl2, 5 mM 
NaHCO3, 20 mM HEPES, pH = 7.4) with 10 mM glucose using a 5 ml Teflon-glass 
homogenizer.  The P2 suspensions were transferred to the top of a discontinuous Percoll™ 
gradient (4%, 10%, 15%, and 23% Percoll™ in ice-cold sucrose buffer, pH = 7.4) and 
centrifuged at 32,500 g for 10 min at 4 °C.  Of the 5 bands formed between the sucrose-
percoll layers in the gradient, bands 3 and 4 (containing the purified synaptosomes), were 
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collected by aspiration and placed into 2 new tubes filled with saline A buffer containing 
glucose.  After mixing, the washed synaptosomes were collected by centrifuging at 
15,000 g for 10 min at 4 °C.  The supernatant was decanted and the purified 
synaptosomal pellets were resuspended manually using a 5 ml Teflon-glass homogenizer 
into a total of ~4 ml saline A with glucose. 
 
2.6 Synaptosome Protein Determination 
 
Synaptosomal protein concentration was determined spectrophotometrically using 
the bicinchoninic acid (BCA) assay (Smith et al., 1985).  Protein induced color changes 
were measured with a UVMAX kinetic microplate spectrophotometer at λ = 560 nm 
(Molecular Devices, Sunnyvale, CA).  Protein concentrations were extrapolated from a 
standard curve using bovine serum albumin (BSA) as the standard protein.  The standard 
curve was constructed by plotting absorbance (O.D.) as a function of the amount of BSA 
and synaptosomal protein values were estimated from the linear regression of the data 
generated from the standards.   
 
2.7 Neurotransmitter Release Assay 
 
Endogenous neurotransmitter release from synaptosomes was determined using 
an enzyme-linked assay with Amplex® UltraRed for the detection of L-glutamate as 
previously described (Nicholls, D.G. 1987; Symington, S.B. 2005).  Purified 
synaptosomes were diluted in saline A buffer with glucose to a final protein 
concentration of 2 mg/ml and incubated with the appropriate pretreatments (antagonists) 
and treatments (pyrethroids).  Solvent concentration during the addition of an antagonist 
   39 
          
did not 0.2% DMSO/ethanol or 1% water when added to synaptosomes for pretreatment 
(5 min at 37 oC).  Pretreatments were followed by treatment with 0.2 µl of a 1000-fold 
concentrated stock solution of each pyrethroid binary mixture in DMSO or DMSO alone 
as a solvent control (99.9 % DMSO for a total DMSO concentration of 0.2%) for 20 min 
at 37 oC prior to the start of each assay.  Treated synaptosomes were added to 1.4 ml of 
warmed (37 oC) saline B buffer with 10 mM glucose (2 mM CaCl2, 125 mM NaCl, 5 mM 
KCl, 1.2 mM MgCl2, 20 mM HEPES, pH = 7.4) containing 50 µM Amplex®, 0.04 U/ml 
glutamate oxidase, and 0.125 U/ml horseradish peroxidase and aliquoted (150 µl/well) to 
a 96-well microtiter plate.  The plate was mixed for 5 sec and basal fluorescence 
monitored (0-2 min) (Exλ = 530 nm and Emλ = 591 nm) at 37 °C using a Gemini-XS 
SPECTRAmax® fluorescent microplate reader (Molecular Devices, Sunnyvale, CA) 
equipped with SOFTmax® Pro software, Version 3.1.2 for Windows-PC (Molecular 
Devices).  Synaptosomes were subsequently depolarized by adding 5 µl aliquots of KCl 
stock solutions (4, 8, 20, 40, or 60 mM final assay KCl concentration) and the net 
increase in the amount of L-glutamate released was determined from fluorescence 
recordings at 30 min post-depolarization.  The 30 min incubation ensures quantitative 
detection of L-glutamate released (Invitrogen Product Information A12221) that occurs 
during the first ~10 s of depolarization (Wennemuth, G. 2000).   
The total L-glutamate content of synaptosomes was determined using the 
nonionic detergent, 0.5% Triton X-100.  Percent L-glutamate release was then calculated 
as indicated by Equation 1 (Symington, S.B. 2007b). 
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Equation 1 
 
100 x 
essynaptosom ofcontent  glutamate Total
tiondepolariza before released Glutamate-L  -tion depolarizaafter  released Glutamate
   Released GlutamatePercent 






=
 
 
Values for endogenous neurotransmitter (L-glutamate) released were extrapolated 
from a standard curve.  The L-glutamate standard curve was set up exactly as the 
neurotransmitter release assay, except in the absence of synaptosomes.  Serial dilutions of 
L-glutamate (0-450 pmoles) were added (5 µl/well) in place of synaptosomes to a 96-well 
microtiter plate and fluorescence monitored as above. A standard curve was constructed 
by plotting the relative fluorescence units (RFU) generated as a function of the amount of 
L-glutamate present.   
 
2.8 Assessment of the Effects of Antagonists and Pyrethroids 
 
The data were first fit to a linear regression (Equation 2) using GraphPad Prism 
Software (Version 3.02, GraphPad Inc., San Diego, CA) to determine if the relationship 
between increasing concentration of the antagonist and the effect on L-glutamate release 
had a slope that was significantly different from zero.  Slopes that were not significantly 
different from zero as determined by Equation 2 were not further evaluated for a 
concentration-dependent response.  If the slope was significantly different from zero, the 
data were fit to the polynomial first order (Equation 2) and the sigmoidal dose-response 
(variable slope) equation (Equation 3) using GraphPad Prism Software (Version 3.02, 
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GraphPad Inc., San Diego, CA), and compared with an F-test to determine which 
equation fit the data best.  Data that best fit Equation 2 were considered non-sigmoidal 
and EC50 values not determined.  Data that best fit Equation 3 displayed a concentration-
dependent response and EC50 values were determined.   
Pyrethroid EC50 values were determined from concentration-dependent response 
curves previously generated by Frisbie (Frisbie, R.K. 2006).  These data were used to 
establish a potency ratio that equalizes the potency of each antagonist and pyrethroid 
used in the generation of each binary mixture.  
 
Equation 2 
 
y  = mx + b 
 
Where: 
y  = Independent variable of the function x. 
m  = Slope of the line. 
b  = Y-intercept of the line. 
x  = Independent variable of the function y. 
 
Equation 3 
)10  (1  /)β - (β   β Response Slope)  X)(Hill- EC (log0max0 50++=
 
Where: 
β0= 0 (Constant). 
βmax = Efficacy Value. 
EC50 = Potency Value, effective concentration producing 50% maximal response. 
Hill Slope = Slope of the concentration-response curves and describes binding 
characteristics. If the Hill Slope is far from 1, receptor-ligand binding does not follow the 
law of mass action for a single site of action, but suggests multiple binding sites. A 
positive (+) Hill Slope suggests cooperative receptor-ligand interaction and a negative (-) 
Hill slope suggests noncooperative receptor-ligand interaction. 
X = Log concentration of pyrethroid. 
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Antagonist and pyrethroid interactions on L-glutamate release were assessed by 
measuring the percent additivity (% additivity), which provides an efficacy measurement 
of interactions in binary mixtures (Equation 4) as described (Martin et al., 2003) with the 
following modifications (Frisbie, R.K. 2006). 
Actual response values obtained for each binary mixture were compared to the 
theoretical response values to determine an additive, more-than-additive, or less-than-
additive relationship between pyrethroids or toxin and pyrethroid binary mixtures 
(Frisbie, R.K. 2006).   
 
Equation 4 
 
 
Where: 
Theoretical Response = Assay response value of a toxin at its EC50 added to the assay 
response value of a pyrethroid at its EC50 or pyrethroid 1 at its EC50 added to the assay 
response value of pyrethroid 2 at its EC50. 
 
Actual Response = Assay response value of the binary mixture at each component’s 
EC50. 
 
a
 A positive percent additivity value indicates a more than additive response. 
b
 A negative percent additivity value indicates a less than additive response. 
c
 A value of 0 indicates additive response.   
 
 
 
 
100 x   
Response   lTheoretica 
Response   lTheoretica   -  Response  Actualy  Additivit  C Less or   More   % b a  
 
 
  
 
 
=
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2.9 Statistical Analysis of Data 
 
Unless otherwise stated, mean values (± S.E.) for L-glutamate release were 
determined from at least three synaptosome preparations using the average values 
obtained from eight replicates per synaptosome preparation (n ≥ 3).  Statistical 
significance of L-glutamate released due to treatment was assessed by the unpaired t-test 
(GraphPad Prism Version 3.02) using P < 0.05 as a criterion for evaluation.  For 
antagonist and binary mixture evaluations, statistically significant differences in L-
glutamate release were assessed using unpaired t-tests (GraphPad Prism Version 3.02) at 
P < 0.05.  A one-way ANOVA using Tukey’s multiple comparison post-test was used to 
compare all possible combinations of treatments and determine statistical significance of 
L-glutamate released (GraphPad Prism Version 3.02) using P < 0.05 as a criterion for 
evaluation. 
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CHAPTER 3 
 
EFFECTS OF SELECTED CHLORIDE CHANNEL ANTAGONISTS ON 
PYRETHROID-ENHANCED NEUROTRANSMITTER RELEASE FROM 
SYNAPTOSOMES 
 
3.1 Effect of Chloride Channel Antagonists on L-Glutamate Release 
 
Rat brain synaptosomes, depolarized with 20 mM KCl, were used to evaluate the 
effects of selected chloride channel antagonists on L-glutamate release in equipotent 
binary mixtures with either cypermethrin, deltamethrin, fenpropathrin or tefluthrin to 
determine if chloride channels are involved in the more-than-additive response previously 
reported by Frisbie (Frisbie, R.K. 2006).  The EC50 values of the chloride channel 
antagonists were determined from concentration-dependent response curves (Fig. 3) 
whereas pyrethroid EC50 values were previously determined (Frisbie, R.K. 2006).  
Three criteria were used to determine if the selected chloride channel antagonists 
elicited a concentration-dependent response on L-glutamate release.  The data were 
initially fit to Equation 2 (Section 2.8) to determine a treatment effect (data generated a 
liner regression response that had a slope significantly different zero).  If the data met this 
criterion, Equation 3 (Section 2.8) was used by fitting the data to the Hill equation to 
determine if there was a concentration-dependent response between L-glutamate release 
and the dose of the antagonist.  Lastly, an F-test was used to determine the best fit of the 
data to either Equations 2 or 3.   
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Of the five antagonists tested, only NPPB elicited a concentration-dependent 
response curve that satisfied all three criteria (F-test, F = 208.2, P < 0.0001, respectively) 
(Fig. 3).  The concentration-dependent response curve of 9-AC did not reach saturating 
conditions at its limit of solubility (~4 mM) (Weinreich, F. 2001), however, the slope was 
significantly different from zero as determined by Equation 2 and the data generated a 
concentration-dependent response as determined by Equation 3 (Fig. 3).  Since GraphPad 
Prism (Version 3.02) was able to fit the data to Equation 3 and generate an EC50 value 
that was consistent with the literature (Weinreich, F. 2001) despite failure of the F-test 
(F-test, F = 1.21, P = 0.5406), 9-AC was used to in the presence of deltamethrin to 
determine if a more-than-additive response could be elicited.   
ClTx and DNDS also increased L-glutamate release with slopes significantly 
different from zero (Equation 2).  GraphPad Prism was able to fit the data to 
concentration-dependent response curves and extrapolate an EC50 value for both 
antagonists.  These values were consistent with those reported by the vendor (Alomone 
Labs product information sheet) and in the literature (Dalton, S. 2003), respectively. 
Nevertheless, both antagonists were determined to fit the linear regression equation the 
best (F-test, F = 0.339 and 4.486, respectively and P = 0.7468 and 0.3167, respectively) 
(Fig. 3). The PTX data did not establish a concentration-response relationship that was 
significantly different from zero (Equation 2), and hence was not further examined in the 
remaining experiments. 
Table 6 summarizes the effects of increasing concentrations of chloride channel 
antagonists on L-glutamate release.  As judged by their estimated EC50s, antagonists 
varied by ~ 3 orders of magnitude (7500-fold) from the least potent (9-AC, 2.4 x 10-4 M) 
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to the most potent (ClTx, 3.21 x 10-8 M).  Data are reported as means ± SE of 3 replicates 
from 3 synaptosomal preparations for 9-AC, 7 replicates from 7 synaptosomal 
preparations for ClTx, 9 replicates from 6 synaptosomal preparations for DNDS, and 7 
replicates from 4 synaptosomal preparations for NPPB. 
 In terms of maximal response (efficacy), however, NPPB was the most 
efficacious at eliciting L-glutamate release from synaptosomes followed by (in order of 
decreasing efficacy) ClTx, DNDS, and 9-AC (Table 6).  Antagonists varied by 7.7- fold 
from the least efficacious (9-AC, 3.64 % ± 4.79) to the most efficacious (NPPB, 28 % ± 
1.38).   
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Figure 3.   Effect of increasing concentrations of chloride channel antagonists on L-
glutamate release from K+-depolarized synaptosomes. Anthracene-9-carboxylic acid (9-
AC), rChlorotoxin (ClTx), 4,4’-dintitrostilbene-2,2’-disulfonic acid (DNDS), 5-nitro-2-
(3-phenylpropylamino) benzoic acid (NPPB), Picrotoxinin (PTX). KCl (20 mM) was 
used to depolarize synaptosomes.  Concentration-dependent response curves were fit with 
the sigmoidal dose-response (variable slope) function in GraphPad Prism version 3.02.  
Data are reported as means ± SE of at least 3 replicates from multiple synaptosome 
preparations (n > 3) and presented as percents over solvent controls. 
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Table 6.  The effects of increasing concentrations of chloride channel antagonists on L-glutamate release from rat brain 
synaptosomes. 
 
Hill Slopea 
(± SE) 
EC50 [M]a 
(± 95% CI) 
Maximum Responsea 
(% Over Control) 
(± SE) 
R2b 
Antagonists 
9-ACc 0.58 (±1.09) 2.4 x 10
-4
 
( 1.6 x 10-37 to 3.6 x 10+29 ) 3.64 (± 4.79) 0.98 
ClTx 0.76 (±0.88) 3.2 x 10
-8
 
( 5.1 x 10-11 to 2.0 x 10-5 ) 4.07 (± 1.15) 0.96 
DNDS 1.60 (±0.81) 8.7 x 10
-7
 
( 1.1 x 10-9 to 7.0 x 10-6 ) 3.66 (± 0.15) 0.99 
NPPB 0.65 (± 0.07) 2.3 x 10
-4
 
(1.2 x 10-4 to 4.4 x 10-4) 28.0 (± 1.38) 0.99 
a
 Estimates were derived from the Hill equation using GraphPad Prism (version 3.02). 
b
 Correlation Coefficient. 
c  Saturation was not achieved at highest concentration examined. 
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3.2 Effect of Pyrethroids in Equipotent Binary Mixtures with Chloride Channel 
Antagonists on L-glutamate Release from Synaptosomes 
 
Chloride channel antagonists (9-AC, ClTx, DNDS, and NPPB) at their respective 
EC50 values were incubated with cypermethrin (type II, CS-syndrome), deltamethrin 
(type II, CS-syndrome), fenpropathrin (type II, T-syndrome), and tefluthrin (type I, T-
syndrome) at their respective EC50 values to determine if chloride channels play a role in 
the more-than-additive effect previously seen with the four binary mixtures of 
pyrethroids reported by Frisbie (Frisbie, R.K. 2006). 
9-AC (1 x 10-4 M) in the presence of deltamethrin (2 x 10-12 M) had no effect on 
L-glutamate release (Fig. 4).  Compared to the theoretical mixture response (assay 
response value of synaptosomes in the presence of 9-AC alone at its EC50 added to the 
assay response value of deltamethrin alone at its EC50), 9-AC in the presence of 
deltamethrin increased L-glutamate release 1.6-fold, however, this increase was not 
statistically significant and therefore was not considered to contribute to the more-than-
additive response (unpaired t-test, P = 0.9562) (Fig. 4 and Table 7).  Because none of the 
treatments were significantly different from each other (One-way ANOVA, Tukey’s 
multiple comparison post-test, GraphPad Prism, Version 3.02) and since 9-AC did not 
elicit a more-than-additive response on L-glutamate release in the presence of 
deltamethrin, the remaining pyrethroids were not similarly tested.   
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Figure 4.  Percent additivity of an equipotent binary mixture of 9-AC and deltamethrin 
(both at their respective EC50s), on L-glutamate release from rat brain synaptosomes.  
Data are reported as means ± SE of 7 replicates from multiple synaptosome preparations 
(n = 3) and are presented as percents over the solvent control.  An asterisk (*) indicates 
that concentration used in the assay was obtained from literature.  Values in parentheses 
indicate a negative response on L-glutamate release. 
 
Abbreviations:  Delta = deltamethrin 
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ClTx (1 x 10-7 M) in the presence of deltamethrin
 
(2 x 10-12 M) significantly 
increased L-glutamate release 26-fold compared to synaptosomes treated with ClTx alone 
(unpaired t-test, P = 0.004).  This release was increased 1.5-fold compared to 
synaptosomes treated with deltamethrin alone, but this increase was not significant 
(unpaired t-test, P = 0.2727) (Fig. 5).  The actual response value of ClTx in binary 
mixture with deltamethrin increased L-glutamate release 1.5-fold compared to the 
theoretical mixture response, but the increase was not significant (unpaired t-test, P = 
0.4124).  Using the percent additivity equation (Equation 4), the actual response 
increased 48% over the theoretical.  This increase, nevertheless, was not statistically 
significant indicating that a more-than-additive response was not generated (unpaired t-
test, P = 0.412) (Fig. 5 and Table 7).  Using the one-way ANOVA and Tukey’s multiple 
comparison post-test, it was determined that none of the treatments were actually 
significantly different from each other, with the exception of ClTx plus deltamethrin 
compared to ClTx alone (GraphPad Prism, Version 3.02).  Since ClTx did not elicit a 
more-than-additive response on L-glutamate release when in the presence of 
deltamethrin, the remaining pyrethroids were not similarly tested.   
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Figure 5.  Percent additivity of an equipotent binary mixture of ClTx and deltamethrin, 
(both at their respective EC50s), on L-glutamate release from rat brain synaptosomes.  
Data are reported as means ± SE of 9 replicates from multiple synaptosome preparations 
(n = 7) and are presented as percents over the solvent control.  A closed circle (●) 
indicates that respective treatment is significantly greater than NT + ClTx treatment 
(unpaired t-test, p < 0.05, GraphPad Prism version 3.02).   
 
Abbreviations:  Delta = deltamethrin 
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DNDS (2 x 10-6 M) in the presence of deltamethrin (2 x 10-12 M) increased L-
glutamate release ~ 5-fold compared to synaptosomes treated with DNDS alone and 1.4-
fold compared to synaptosomes treated with deltamethrin alone (Fig. 6).  None of the 
increases were, however, significant (unpaired t-test, P = 0.2627 and 0.5111, 
respectively).  The actual response value of DNDS in binary mixture with deltamethrin 
increased release 1.1-fold compared to the theoretical mixture response, however, this 
increase was not statistically significant.  Thus a more-than-additive response was not 
generated (unpaired t-test, P = 0.9281) (Fig. 6 and Table 7).  Furthermore, none of the 
treatments were significantly different from each other (One-way ANOVA, Tukey’s 
multiple comparison post-test, GraphPad Prism, Version 3.02).   
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Figure 6.  Percent additivity of an equipotent binary mixture of DNDS and deltamethrin 
(both at their respective EC50s), on L-glutamate release from rat brain synaptosomes.  
Data are reported as means ± SE of 4 replicates from multiple synaptosome preparations 
(n = 4) and are presented as percents over the solvent control.  An asterisk (*) indicates 
that concentration used in the assay was obtained from literature.     
 
Abbreviations:  Delta = deltamethrin 
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NPPB (7 x 10-5 M) in the presence of deltamethrin (2 x 10-12 M) (reported as 
means ± SE of 18 replicates from 7 synaptosomal preparations) significantly increased L-
glutamate release 3.4-fold compared to synaptosomes treated with NPPB alone (unpaired 
t-test, P < 0.0001) and 3.5-fold compared to synaptosomes treated with deltamethrin 
alone (unpaired t-test, P < 0.0001) (Fig. 7A).  The actual response value of NPPB in 
binary mixture with deltamethrin significantly increased L-glutamate release 1.7-fold 
compared to the theoretical mixture response (unpaired t-test, P = 0245).  Using the 
percent additivity equation (Equation 4), the actual response increased 73% over the 
theoretical and was determined to have elicited a more-than-additive response on L-
glutamate release (Fig 7A and Table 7).  In addition, only the actual treatment of 
deltamethrin plus NPPB was determined to be significantly different from all other 
treatments (One-way ANOVA, Tukey’s multiple comparison post-test, GraphPad Prism, 
Version 3.02). 
To assess if this more-than-additive response was only generated by the NPPB 
plus deltamethrin mixture, NPPB was likewise examined in binary combinations with a 
slightly less potent type II pyrethroid that modifies VGSCs, VGCCS, and VGClCs, 
cypermethrin (Fig. 7B); a pyrethroid that is type II, but exhibits the T-syndrome and 
modifies VGSCs and VGClCs, fenpropathrin (Fig. 7C); and a type I pyrethroid that 
modifies VGSCs only, tefluthrin (Fig. 7D).  Cypermethrin and NPPB (2 x 10-10 and 7 x 
10-5 M, respectively) in binary mixture (reported as means ± SE of 4 replicates from 4 
synaptosomal preparations) significantly increased L-glutamate release ~ 35-fold 
compared to synaptosomes treated with NPPB alone (unpaired t-test, P = 0.0056) and 
significantly increased L-glutamate release 4.5-fold compared to synaptosomes treated  
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Figure 7.  Percent additivity of an equipotent binary mixture of NPPB and deltamethrin 
(A), cypermethrin (B), fenpropathrin (C), and tefluthrin (D), (both at their respective 
EC50s) on L-glutamate release from rat brain synaptosomes.  Data are reported as means 
± SE of at least 3 replicates from multiple synaptosome preparations (n >3) and are 
presented as percent over the solvent control.  A closed circle (●) indicates that respective 
treatment is significantly greater than NT + NPPB treatment (unpaired t-test, p < 0.05, 
GraphPad Prism version 3.02).  An open triangle (∆) indicates that respective treatment is 
significantly greater than pyrethroid treatment alone (unpaired t-test, p < 0.05, GraphPad 
Prism version 3.02).  A closed square (■) indicates that respective treatment is 
significantly greater than theoretical mixture (unpaired t-test, p < 0.05, GraphPad Prism 
version 3.02). 
 
Abbreviations:  Delta = deltamethrin, Cyper = cypermethrin, Fenpro = fenpropathrin, and 
Tef = tefluthrin. 
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with cypermethrin alone (unpaired t-test, P = 0.0166) (Fig. 7B).  The actual response 
value of NPPB in binary mixture with cypermethrin significantly increased 4-fold 
compared to the theoretical mixture response (unpaired t-test, P = 0.0308).  Using the 
percent additivity equation (Equation 4), the actual response significantly increased L-
glutamate release 298% over the theoretical mixture (Fig. 7B).  In addition, only the 
actual treatment of cypermethrin plus NPPB was determined to be significantly different 
from all other treatments (One-way ANOVA, Tukey’s multiple comparison post-test, 
GraphPad Prism, Version 3.02). 
NPPB in the presence of fenpropathrin (7 x 10-5 and 2 x 10-9 M, respectively) 
(reported as means ± SE of 11 replicates from 6 synaptosomal preparations) significantly 
increased L-glutamate release 4-fold compared to synaptosomes treated with NPPB alone 
(unpaired t-test, P = 0.0005) and significantly increased L-glutamate release 4.4-fold 
compared to synaptosomes treated with fenpropathrin alone (unpaired t-test, P < 0.0001) 
(Fig. 7C).  The actual response value of NPPB in binary mixture with fenpropathrin 
significantly increased 2-fold compared to the theoretical mixture response (unpaired t-
test, P = 0.0121).  Using the percent additivity equation (Equation 4), the actual response 
increased significantly 112% over the theoretical mixture (Fig. 7C).  In addition, only the 
actual treatment of fenpropathrin plus NPPB was determined to be significantly different 
from all other treatments (One-way ANOVA, Tukey’s multiple comparison post-test, 
GraphPad Prism, Version 3.02). 
NPPB in the presence of tefluthrin (7 x 10-5 and 2 x 10-8 M, respectively) 
(reported as means ± SE of 7 replicates from 4 synaptosomal preparations) significantly 
increased L-glutamate release 4.4-fold compared to synaptosomes treated with NPPB 
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alone (unpaired t-test, P = 0.0038) and significantly increased L-glutamate release 10-
fold compared to synaptosomes treated with tefluthrin alone (unpaired t-test, P = 0.0004) 
(Fig. 7D).  The actual response value of NPPB in binary mixture with tefluthrin 
significantly increased 3-fold compared to the theoretical mixture response (unpaired t-
test, P = 0.0162).  Using the percent additivity equation (Equation 4), the actual response 
increased significantly 208% over the theoretical mixture (Fig. 7D).  In addition, only the 
actual treatment of tefluthrin plus NPPB was determined to be significantly different 
from all other treatments (One-way ANOVA, Tukey’s multiple comparison post-test, 
GraphPad Prism, Version 3.02). 
 Since tefluthrin modifies only VGSCs, the addition of a chloride channel 
antagonist such as NPPB should mimic the response seen with fenpropathrin, which 
modifies both VGSCs and VGClCs.  When the assay response of fenpropathrin alone 
(2.15 % ± 0.57) was compared to the assay response of tefluthrin in an equipotent binary 
mixture with NPPB (7.03 % ± 1.07), it was found that the L-glutamate release increased 
by 3.3-fold and was statistically significant (unpaired t-test, P = 0.0004).  When the assay 
response of tefluthrin in an equipotent binary mixture with NPPB was compared to the 
assay response of deltamethrin alone (2.41 % ± 0.64), L-glutamate release increased 2.9-
fold and was statistically significant (unpaired t-test, P = 0.003). Likewise, when 
tefluthrin in the presence of NPPB was compared to cypermethrin alone (2.0 % ± 1.24), 
L-glutamate release significantly increased 3.5-fold (unpaired t-test, P = 0.0261).    
Table 7 summarizes the effect of chloride channel antagonists at their estimated 
EC50s on L-glutamate release in the presence of deltamethrin at its EC50 (2 x 10-12 M) on 
rat brain synaptosomes.   
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Table 7:  Effect of chloride channel antagonists at their EC50s on L-glutamate release from rat brain synaptosomes in 
the presence of deltamethrin at its EC50 (2 x 10-12 M). 
 EC50 
Theoretical Responsea 
(± SE) 
Actual Responseb 
(± SE) 
Significantly 
Different 
(p < 0.5) 
% 
Additivityc 
 
Antagonist 
9-AC 0.1 mM 0.48% (± 4.60) 0.77 % (± 2.39) No - 
ClTx 0.1 µM 2.80 % (± 1.07) 4.08 % (± 1.10) No 48 % 
DNDS 2 µM 4.37% (± 3.98) 4.77% (± 1.61) No - 
NPPB 70 µM 4.85% (± 1.17) 8.37% (± 0.71) Yes 73 % 
a
 Theoretical response determined by the sum of the individual L-glutamate release response values in the presence of each 
pyrethroid alone at its EC50. 
b
 Actual response is the lowest concentration of pyrethroids in binary mixture observed that exhibited a more-than-additive 
response on L-glutamate release in the presence of NPPB (70 µM). 
c
  Percent (%) additivity values for pyrethroid binary mixtures were calculated using Equation 4 (Section 2.8). 
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3.3 Discussion 
 
Concentration-response curves were generated for four of the five chloride 
channel antagonists, 9-AC, ClTx, DNDS, and NPPB, all of which increased L-glutamate 
release from rat brain synaptosomes.  The estimated EC50 values for 9-AC, ClTx, DNDS, 
and NPPB (2.39 x 10-4 M, 3.21 x 10-8 M, 1.65 x 10-6 M, and 2.30 x 10-4, respectively) 
from our concentration response curves were consistent with previously established 
potency values in similar neuronal preparations (Weinreich, F. 2001; Clark, S. 1998; 
Dalton, S. 2003; Okada, Y. 2000).   
PTX failed to elicit a treatment response on L-glutamate release that was 
significantly different from a slope of zero.  Historically, the modulation of GABAAClCs 
by the inhibitory neurotransmitter, GABA, has been well established as occurring on 
postsynaptic targets (Jang, I.S. 2006).  Recent evidence, however, suggests that these 
receptors are found also on presynaptic membranes (Zhang, S.J. 1993; Vautrin, J. 1994; 
Jang, I.S. 2006).  Because of this, it is not clear why PTX was incapable of eliciting a 
concentration-dependent response on L-glutamate release from rat brain synaptosomes.  
Although the level of expression of these receptors is not known in our preparation, it is 
possible that the neurotransmitter release assay is too insensitive to detect the amount of 
L-glutamate release due to inhibition of GABAAClCs.  In addition, Vautrin et al. describe 
mechanisms by which synaptic transmission is mediated and seems likely that rat brain 
synaptosomes modulate transmission via presynaptic auto-transmission or “cis-mission” 
(Vautrin, J. 1994).  If this were true, then it would be expected that both excitatory and 
inhibitory neurotransmitters would feedback on their respective receptors on the 
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presynaptic nerve terminal and an inability of one receptor to mediate synaptic 
transmission this way is expected to be the same for other receptors.   
Using the established potency values for 9-AC, ClTx, DNDS, and NPPB, 
equipotent binary mixtures of the chloride channel antagonists and pyrethroids could be 
examined for a potential contribution of chloride channels to the more-than-additive 
response on L-glutamate release.   
Deltamethrin was chosen as the initial pyrethroid to test because it has been 
established previously as the most potent pyrethroid on L-glutamate release from rat 
brain synaptosomes (Frisbie, R.K. 2006).  Since the neurotoxic action of deltamethrin 
includes the modification of neuronal VGClC in addition to VGSC and VGCC (Chinn, 
K. 1986; Symington, S.B. 2005; Forshaw, P.J. 1990), it was hypothesized that blocking 
chloride channels with selective antagonists in the presence of deltamethrin should 
increase L-glutamate release and contribute to the more-than-additive response.   
Collectively, our findings indicated that only NPPB was capable of significantly 
increasing L-glutamate release 73% when in equipotent binary mixtures with 
deltamethrin and reproduce the more-than-additive response previously seen with certain 
binary mixtures of pyrethroids (Frisbie, R.K. 2006).  Although the equipotent binary 
mixture of ClTx and deltamethrin was not significantly different from the theoretical 
response, the percent additivity of this equipotent binary mixture was calculated (48%) 
for comparative purposes since ClTx was previously established as the most potent of all 
the tested antagonists.  Additionally, the treatments were determined to be significantly 
different from each other using the one-way ANOVA and Tukey’s multiple comparison 
post-test.  9-AC and DNDS did not significantly increase L-glutamate release in the 
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presence of deltamethrin and treatments were not determined to be significantly from 
each other.  Hence, these compounds were not investigated further.   
The effect of NPPB on L-glutamate release was investigated with three additional 
pyrethroids.  Cypermethrin, like deltamethrin, has been shown to modify the gating 
kinetics of VGSCs, VGCCs, and VGClCs.  Fenpropathrin modifies VGSCs and VGClCs, 
while tefluthrin modifies only VGSCs (Soderlund, D.M. 2002; Frisbie, R.K. 2006; Burr, 
S.A. 2004).  In all three respective equipotent binary mixtures with cypermethrin, 
fenpropathrin, and tefluthrin, NPPB significantly increased L-glutamate release by 298, 
112, and 208 %, respectively, when compared to the theoretical assay response and all 
treatments were significantly different from each other, as determined by the one-way 
ANOVA.   
A more-than-additive response of L-glutamate release from rat brain 
synaptosomes occurred in the presence of binary mixtures of pyrethroids where at least 
one of the two pyrethroids increased neurotransmitter release and the other pyrethroid 
had an action on VGClCs (Frisbie, R.K. 2006).  This phenomenon is likewise seen only 
in the combined presence of a pyrethroid that increases L-glutamate release and a 
chloride channel antagonist which blocks VGClCs in presynaptic nerve terminals, such as 
ClTx and NPPB, indicating that blockage of VGClCs may be necessary for the 
generation of the more-than-additive response.   
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CHAPTER 4 
 
EFFECTS OF CHLORIDE CHANNEL ANTAGONIST ON 
NEUROTRANSMITTER RELEASE FROM SYNAPTOSOMES IN THE 
COMBINED PRESENCE OF EQUIPOTENT PYRETHROID BINARY 
MIXTURES 
 
4.1 Effect of NPPB on Pyrethroid Binary Mixtures that Produced a More-Than-
Additive Response on L-Glutamate Release 
 
 The potency (EC50) value for NPPB on L-glutamate release was determined from 
concentration-dependent response data as 70 µM (Section 3.1) and used in the presence 
of two equipotent binary mixtures of pyrethroids (deltamethrin plus cypermethrin and 
deltamethrin plus fenpropathrin) that produced more-than-additive responses (Frisbie, 
R.K. 2006).   
Figure 8A depicts the effects of deltamethrin and cypermethrin, individually and 
in binary mixture, on endogenous L-glutamate release (Frisbie, R.K. 2006).   
Synaptosomes were treated with either the EC50 of deltamethrin alone (2 x 10-12 M, final 
concentration), cypermethrin alone (2 x 10-10 M, final concentration) or with binary 
mixtures of deltamethrin and cypermethrin.  Binary mixtures ranged from a 1:1 to 1:100 
ratio of 2 x 10-12 M deltamethrin with increasing concentrations of cypermethrin (2 x 10-
12
 M to 2 x 10-10 M) (final total pyrethroid concentrations were 4 x 10-12 M to 2.02 x 10-10 
M).  A combined theoretical mixture response of deltamethrin and cypermethrin (4 x 10-
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12
 M, final concentration) was generated by the addition of the assay response values for 
the two pyrethroids determined individually at their respective EC50 values.   
Figure 8B depicts the effects of deltamethrin and cypermethrin individually and in 
binary mixture with 70 µM NPPB on endogenous L-glutamate release.  Treatments were 
conducted as described above, but in the presence of 70 µM NPPB. All binary mixtures 
tested (1:1, 1:10, 1: 100), significantly increased (7.4-, 8.6-, 6.7-fold respectively) L-
glutamate release compared to the deltamethrin treatment alone (0.78% ± 0.69) (unpaired 
t-test, P = 0.0036, 0.0062, and 0.0091, respectively).   
When compared to the theoretical mixture, the deltamethrin plus cypermethrin 
actual mixtures (1:1, 1:10, 1:100) in the presence of NPPB  increased  L-glutamate 
release 2.7-, 3.1-, and 2.4-fold, respectively.  However, only the 1:1 and 1:10 mixtures 
resulted in statistically greater release (unpaired t-test, P = 0.0293, 0.0300, and 0.0659, 
respectively).   Using the % additivity criteria (Equation 4), the 1:1 ratio of deltamethrin 
plus cypermethrin with NPPB at the 1:1 ratio ( 5.80 % ± 1.02) elicited a more-than-
additive response that was 166 % more than the theoretical response  (2.18 % ± 0.91) 
(Fig. 8B) .  Thus, the more-than-additive response previously reported in the absence of 
NPPB (1:100) (Fig. 8A) (Frisbie, R.K. 2006) was shifted to a lower concentration of 
cypermethrin by one order of magnitude (1:10) (Fig. 8B)     
Figure 9A depicts the effects of deltamethrin plus fenpropathrin, individually and 
in binary mixture, on endogenous L-glutamate release (Frisbie, R.K. 2006).  
Synaptosomes were treated with either the EC50 of deltamethrin alone (2 x 10-12 M, final 
concentration), fenpropathrin alone (2 x 10-8 M, final concentration) or with  
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Figure 8:  Determination of additivity between deltamethrin and cypermethrin in the 
absence (A) (reproduced from Richard K. Frisbie M.S. thesis, University of 
Massachusetts, Amherst, © 2006) and presence (B) of NPPB (70 µM), on L-glutamate 
release from rat brain synaptosomes.  Values reported are means ± SE of 10 replicates 
from multiple synaptosomal preparations (n = 5).  KCl (20 mM) was used to depolarize 
synaptosomes.  Synaptosomes were treated with either the EC50 of deltamethrin alone 
([final assay] 2 x 10-12 M), the EC50 of cypermethrin alone ([final assay] 2 x 10-10 M) or a 
binary mixture in the presence of NPPB (70 µM).  An asterisk (*) indicates the 
theoretical mixture response determined as the sum of the individual assay response 
values for deltamethrin and cypermethrin at their respective EC50 values.  A closed circle 
(●) indicates the actual mixture response values for L-glutamate release in the presence 
of NPPB (70 µM) and binary mixtures composed of deltamethrin ([final assay] 2 x 10-12 
M) and increasing concentrations of cypermethrin ([final assay] 2 x 10-12 to 2 x 10-10 M), 
([final total pyrethroid assay] 4 x 10-12 to 2.02 x 10-10 M).  An open triangle (∆) indicates 
that the actual mixture is significantly greater than the deltamethrin treatment alone 
(unpaired t-test, P < 0.05).  A closed square (■) indicates that actual mixture is 
significantly greater than the theoretical response (unpaired t-test, P < 0.05).   
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binary mixtures of deltamethrin and fenpropathrin in the presence of 70 µM NPPB.     
Binary mixtures ranged from a 1:1 to 1:10,000 ratio of deltamethrin to increasing 
concentrations of fenpropathrin (final total pyrethroid concentrations were 4 x 10-12 M to 
2.0002 x 10-8 M).  A combined theoretical mixture response of deltamethrin and 
fenpropathrin (4 x 10-12 M, final concentration) was generated as before. 
Figure 9B depicts the effects of deltamethrin and fenpropathrin individually and 
in binary mixture with 70 µM NPPB on endogenous L-glutamate release.  Treatments 
were conducted as described above, but in the presence of 70 µM NPPB. At all binary 
mixtures (1:1 to 1:10,000) tested, deltamethrin in the presence of increasing 
concentrations of fenpropathrin and 70 µM NPPB, significantly increased  L-glutamate 
release (22-, 21-, 23-, 27-, and 26-fold, respectively) when compared to deltamethrin 
treatment alone (unpaired t-test, P = 0.0007, 0.001, 0.0014, 0.0008, and 0.0003, 
respectively).   
Additionally, all binary mixtures (1:1 to 1:10,000) in the presence of NPPB 
significantly increased L-glutamate release (6.2-, 5.9-, 6.4-, 7.7-, 7.2-fold, respectively) 
when compared to the theoretical mixture (2.0002 x 10-8 M), (unpaired t-test, P = 0.0021, 
0.0033, 0.0037, 0.0019, and 0.0008, respectively).  Using the % additivity criteria 
(Equation 4), the 1:1 ratio of deltamethrin plus fenpropathrin with NPPB elicited a more-
than-additive response that was 524 % more than the theoretical response (1.49 % ± 
0.82).  
Thus, the more-than-additive response previously reported in the absence of 
NPPB (1:1,000) (Fig. 9A) (Frisbie, R.K. 2006) was shifted to a lower concentration of 
fenpropathrin by three orders of magnitude (1:1) (Fig. 9B). 
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Figure 9:  Determination of additivity between deltamethrin and fenpropathrin in the 
absence (A) (reproduced from Richard K. Frisbie M.S. thesis, University of 
Massachusetts, Amherst, © 2006) and presence (B) of NPPB (70 µM), on L-glutamate 
release from rat brain synaptosomes.  Values reported are means ± SE of 5 replicates 
from multiple synaptosomal preparations (n = 3).  KCl (20 mM) was used to depolarize 
synaptosomes.  Synaptosomes were treated with either the EC50 of deltamethrin alone 
([final assay] 2 x 10-12 M), the EC50 of fenpropathrin alone ([final assay] 2 x 10-8 M) or a 
binary mixture in the presence of NPPB (70 µM).  An asterisk (*) indicates the 
theoretical mixture response determined as the sum of the individual assay response 
values for deltamethrin and fenpropathrin at their respective EC50 values.  A closed circle 
(●) indicates the actual mixture response values for L-glutamate release in the presence 
of NPPB (70 µM) and binary mixtures composed of deltamethrin ([final assay] 2 x 10-12 
M) and increasing concentrations of fenpropathrin ([final assay] 2 x 10-12 to 2 x 10-8 M), 
([final total pyrethroid assay] 4 x 10-12 to 2.0002 x 10-8 M).  An open triangle (∆) 
indicates that the actual mixture is significantly greater than the deltamethrin treatment 
alone (unpaired t-test, P < 0.05).  A closed square (■) indicates that the actual mixture is 
significantly greater than the theoretical response (unpaired t-test, P < 0.05).           
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4.2 Effect of NPPB in the Presence of a Pyrethroid Binary Mixture that Produced 
an Additive Response on L-Glutamate Release 
 
To further validate a role of chloride channels in producing the more-than-
additive response seen with certain binary mixtures of pyrethroids, the chloride channel 
antagonist, NPPB, was used in the presence of a binary mixture of pyrethroids that 
elicited an additive response on L-glutamate release.  The potency (EC50) value for the 
chloride channel antagonist, NPPB, was determined from a concentration-response curve 
(Section 3.1) and used in the presence of an additive binary mixture, deltamethrin plus 
tefluthrin (Frisbie, R.K. 2006).   
Figure 10A depicts the effects of deltamethrin and tefluthrin in binary mixture on 
endogenous L-glutamate release.   Synaptosomes were treated with either the EC50 of 
deltamethrin alone (2 x 10-12 M, final concentration), the EC50 of tefluthrin alone (2 x 10-9 
M, final concentration) or with binary mixtures of deltamethrin plus tefluthrin with 70 
µM NPPB.  Binary mixtures ranged from a 1:1 to 1:1,000 ratio of 2 x 10-12 M 
deltamethrin with increasing concentrations of tefluthrin (2x10-12 to 2x10-9 M final 
concentration) (final total pyrethroid concentrations were 4 x 10-12 M to 2.002 x 10-9 M).  
A combined theoretical mixture response of deltamethrin and tefluthrin (4 x 10-12 M, final 
concentration) was generated as before. 
Figure 10B depicts the effects of deltamethrin and tefluthrin individually, and in 
binary mixture with 70 µM NPPB on endogenous L-glutamate release.  Treatments were 
conducted as above, but in the presence of 70 µM NPPB.  All binary mixtures (1:1 to 
1:1,000) in the presence of NPPB significantly increased (17-, 23-, 19-, and 18-fold, 
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respectively) L-glutamate release when compared to the deltamethrin treatment alone 
(unpaired t-test, P = 0.0133, 0.0012, 0.0023, 0.0008, and 0.0022, respectively).  When 
compared to the theoretical treatment, deltamethrin and tefluthrin in the presence of 
NPPB increased L-glutamate release (3.1-, 4.2-, 3.4-, and 3.3-fold, respectively), but only 
the mixtures from 1:10 to 1:1000 were significantly different from the theoretical 
response (unpaired t-test, P = 0.0075, 0.0188, and 0.0207, respectively).  Using the % 
additivity criteria (Equation 4), deltamethrin and tefluthrin in the presence of NPPB at the 
1:10 ratio (7 % ± 1.12) elicited a more-than-additive response that was 324 % more than 
1:1,000 theoretical mixture (1.65 % ± 0.76). 
Overall, these findings suggest that NPPB is capable of synergizing the effect of 
deltamethrin on L-glutamate release from rat brain synaptosomes.   Previous studies have 
shown that deltamethrin and tefluthrin, when in binary combination, elicit only an 
additive response on L-glutamate release (Frisbie, R.K. 2006).  However, the effect of 
these compounds when in binary mixtures, on L-glutamate release, can be enhanced by 
antagonizing the chloride channel.  
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Figure 10:  Determination of additivity between deltamethrin and fenpropathrin in the 
absence (A) (reproduced from Richard K. Frisbie M.S. thesis, University of 
Massachusetts, Amherst, © 2006) and presence (B) of NPPB (70 µM), on L-glutamate 
release from rat brain synaptosomes.  Values reported are means ± SE of 5 replicates 
from multiple synaptosomal preparations (n = 3).  KCl (20 mM) was used to depolarize 
synaptosomes.  Synaptosomes were treated with either the EC50 of deltamethrin alone 
([final assay] 2 x 10-12 M), the EC50 of fenpropathrin alone ([final assay] 2 x 10-8 M) or a 
binary mixture in the presence of NPPB (70 µM).  An asterisk (*) indicates the 
theoretical mixture response determined as the sum of the individual assay response 
values for deltamethrin and fenpropathrin at their respective EC50 values.  A closed circle 
(●) indicates the actual mixture response values for L-glutamate release in the presence 
of NPPB (70 µM) and binary mixtures composed of deltamethrin ([final assay] 2 x 10-12 
M) and increasing concentrations of fenpropathrin ([final assay] 2 x 10-12 to 2 x 10-8 M), 
([final total pyrethroid assay] 4 x 10-12 to 2.0002 x 10-8 M).  An open triangle (∆) 
indicates that the actual mixture is significantly greater than the deltamethrin treatment 
alone (unpaired t-test, P < 0.05).  A closed square (■) indicates that the actual mixture is 
significantly greater than the theoretical response (unpaired t-test, P < 0.05).    
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4.3 Discussion 
 
In order to establish a role of chloride channel blockage in producing the more-
than-additive response on L-glutamate release, NPPB, the most efficacious of the 
chloride channel antagonists identified in our study, was used in the presence of two 
more-than-additive pyrethroid binary mixtures and one additive pyrethroid binary 
mixture previously established by Frisbie.(Frisbie, R.K. 2006). 
Since chloride channels generally function to rectify membrane potential (Hille, 
B. 2001), it was expected that blocking such channels in isolated presynaptic nerve 
terminals (synaptosomes) would increase membrane depolarization and cause an increase 
in L-glutamate alone. 
In the presence of the binary mixtures that elicit a more-than-additive response 
(deltamethrin plus cypermethrin and deltamethrin plus fenpropathrin), it was expected 
that NPPB would shift the more-than-additive response to a lower combined 
concentration of the two pyrethroids in binary mixtures and that the more-than-additive 
response would increase in a concentration-dependent manner as seen by Frisbie. 
(Frisbie, R.K. 2006).  In the presence of an additive binary mixture (deltamethrin plus 
tefluthrin), it was expected that a more-than-additive response on L-glutamate release 
would be generated, but that a concentration-dependent response would not be elicited.   
Our findings indicate that chloride channels do play a role in eliciting a more-
than-additive response. 
  Table 8 summarizes the relationship of binary mixtures of pyrethroids in the 
presence of 70 µM NPPB on endogenous L-glutamate release from rat brain 
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synaptosomes.  Deltamethrin in equipotent binary mixtures with cypermethrin, 
fenpropathrin, and tefluthrin, increased L-glutamate release (166, 524, and 324 % 
respectively) compared to the theoretical response.  These responses were all 
significantly different from the theoretical response, indicating a more-than-additive 
response has occurred as judged by the % additivity criteria (Equation 4). 
Table 9 summarizes the results of adding NPPB to binary mixtures of pyrethroids 
that elicited either more-than-additive or additive responses and compared these effects to 
those elicited by binary mixtures without NPPB.  Deltamethrin plus cypermethrin in the 
absence of NPPB first elicited a more-than-additive response at the 1:100 mixture. With 
NPPB, this response was first detected with the 1:1 mixture.  Thus, the more-than-
additive response was elicited at a 100-fold lower cypermethrin concentration and the 
amount of L-glutamate release was enhanced 2.4-fold compared to synaptosomes treated 
at the 1:100 mixture without NPPB.   
Deltamethrin plus fenpropathrin in the absence of NPPB first elicited a more-
than-additive response at the 1: 1,000 mixture.  With NPPB, this response was first 
detected with the 1:1 mixture. Thus, the more-than-additive response was elicited at a 
1000-fold lower fenpropathrin concentration and the amount of L-glutamate release was 
enhanced 6.6-fold compared to synaptosomes treated at the 1:1,000 mixture without 
NPPB.   
Deltamethrin plus tefluthrin in the absence of NPPB did not elicit a more-than-
additive response.  With NPPB, a more-than-additive response was first detected with the  
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Table 8:  Relationship of binary mixtures of pyrethroids in the presence of NPPB (70 µM) on endogenous L-glutamate release from 
rat brain synaptosomes. 
 
 L-glutamate Released (% of Total L-glutamate) 
Pyrethroid Binary Mixture Ratioa Theoretical Mixture Responseb 
(± SE) 
Actual Mixture Responsec 
(± SE) 
% Additivityd 
Deltamethrin + Cypermethrin 1:1 2.18 (± 0.91) 5.8 (± 1.02)* 166 % 
Deltamethrin + Fenpropathrin 1:1 1.49 (± 0.82) 9.30 (± 1.55)* 524 % 
Deltamethrin + Tefluthrin 1:10 1.65 % (± 0.76) 7.0 % (± 1.12)* 324 % 
a
 Observed potency ratio of pyrethroids in binary mixture that exhibited the more-than-additive response in the presence of NPPB 
(70 µM) where 1 equals the EC50 of deltamethrin (2 x 10-12 M). 
b
 Theoretical response determined by the sum of the individual L-glutamate release response values in the presence of each 
pyrethroid alone at its EC50. 
c
 Actual response is the lowest concentration of pyrethroids in binary mixture observed that exhibited a more-than-additive response 
on L-glutamate release in the presence of NPPB (70 µM). 
d
  Percent (%) additivity values for pyrethroid binary mixtures were calculated using Equation 4 (Section 2.8). 
* An asterisk indicates that the actual mixture response is statistically different from the theoretical mixture response, unpaired t-test, 
P < 0.05 (GraphPad Prism). 
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Table 9:  Comparison of binary mixtures in the absence and presence of NPPB. 
Equipotent Binary Mixture 
Assay Response a,b 
- NPPB (70 µM) 
(± SE) 
Assay Response a 
+ NPPB (70 µM) 
(± SE) 
Fold-increase 
Deltamethrin + Cypermethrin 
1:1 2.4 ( ± 0.17) 5.8 ( ± 1.02) * 2.4 
1:10 2.5 ( ± 0.22) 6.7 ( ± 1.45) 2.7 
1:100 4.4 ( ± 0.26)* 5.22 ( ± 1.10) 1.2 
Deltamethrin + Fenpropathrin 
1:1 1.4 ( ± 0.31) 9.3 ( ± 1.55)* 6.6 
1:10 2.3 ( ± 0.34) 8.8 ( ± 1.57) 3.8 
1:100 2.4 ( ± 0.34) 9.5 ( ± 1.81) 4.0 
1:1,000 4.0 ( ± 0.31)* 11.5 ( ± 2.04) 2.9 
1:10,000 7.6 ( ± 0.46) 10.8 ( ± 1.58) 1.4 
Deltamethrin + Tefluthrin    
1:1 1.3 ( ± 0.52) 5.1 ( ± 1.35) 3.8 
1:10 2.2 ( ± 0.54) 7.0 ( ± 1.12)* 3.2 
1:100 2.53 ( ± 0.37) 5.7 ( ± 1.00) 2.2 
1:1,000 3.0 ( ± 0.50) 5.4 ( ± 0.95) 1.8 
a
 Assay response is the amount of L-glutamate released in the presence of a binary mixture of pyrethroids with or without NPPB. 
b
 Values obtained from work done by Frisbie (Frisbie, R.K. 2006). 
* An asterisk indicates the lowest concentration at which a more-than-additive response L-glutamate release was observed. 
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1:10 mixture.  The amount of L-glutamate release was enhanced 3.2-fold compared to 
synaptosomes treated at the 1:10 mixture without NPPB. 
Overall, the more-than-additive binary mixtures (deltamethrin plus cypermethrin 
and deltamethrin plus fenpropathrin) in the presence of NPPB shifted this response to 
lower binary mixture concentrations and the additive binary mixture (deltamethrin plus 
tefluthrin) in the presence of NPPB elicited a more-than-additive response as expected.  
None of the pyrethroid binary mixtures in the presence of NPPB, however, elicited L-
glutamate release in a concentration-dependent manner.  It is possible that the 
concentration of NPPB used saturated certain chloride channels that are target sites for 
selected pyrethroids and hence a concentration effect on L-glutamate release could not be 
distinguished using the different ratios of pyrethroids in binary mixtures.  Lower 
concentrations of NPPB should be tested to clarify this effect.  In addition, since the 
additive binary mixture, deltamethrin plus tefluthrin with NPPB elicited a more-than-
additive response on L-glutamate release, it is not clear whether this response is due to 
the action of NPPB at the chloride channels alone or if this inhibitor enhances the action 
of tefluthrin at VGSCs.  Therefore, the VGSC inhibitor, tetrodotoxin (TTX), could be 
used in the presence of this pyrethroid binary mixture with NPPB to determine if the 
more-than-additive response is abolished.  If this response is abolished, it suggests that 
modifying chloride channels ultimately modulates sodium conductance via VGSCs and 
this action is important also for pyrethroids that affect only VGSCs.   
Similar to NPPB, ClTx in the presence of select binary mixtures can also enhance 
L-glutamate and shift the more-than-additive response to lower concentrations (Frisbie, 
R.K. 2006).  Deltamethrin plus fenpropathrin in the absence of ClTx first elicited the 
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more-than-additive response at the 1:1,000 mixture.  With ClTx, this response was first 
detected with the 1:10 mixture (2.65 ± 0.26).  Thus, the more-than-additive response was 
elicited at a 100-fold lower fenpropathrin concentration and the amount of L-glutamate 
release was enhanced 1.2-fold compared to synaptosomes treated at the 1:1,000 mixture 
without ClTx.  These findings were not surprising since NPPB and ClTx target the same 
chloride channels (VGClC and CaClC). 
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CHAPTER 5 
 
SUMMARY AND FUTURE DIRECTIONS 
 
Thus far, our findings have implicated the importance of chloride channels in rat 
brain synaptosomes in the acute neurotoxicity response of pyrethroids.  Since NPPB and 
ClTx are known inhibitors of ClC-2 VGClCs and CaClCs and have been shown to 
enhance L-glutamate release, we propose that these channels are present in our 
synaptosomal preparations and are modified by pyrethroids.  PTX did not elicit a 
concentration-dependent response.  It is not clear whether GABAAClC are absent in our 
synaptosome preparation or if the level of expression is so low that our assay is not 
sensitive enough to detect any increase in L-glutamate release due to blockage of these 
channels.   
There are at least two mechanisms by which pyrethroids are capable of eliciting 
increased L-glutamate release from presynaptic nerve terminals that involve blockage of 
the two chloride channels.  In the first model, deltamethrin initially targets VGSCs and 
causes synaptolemma depolarization due to an influx of sodium ions (Fig. 11).  VGCCs 
in active release zones activate in response to membrane depolarization and calcium 
influx is prolonged due to modification by deltamethrin (Symington, S.B. 2007b).  At this 
time, the membrane potential has become significantly more positive than the ECl, and 
under normal circumstances, VGClCs activate allowing negative charge to flux into the 
synaptosome (hyperpolarization) and return the membrane potential back to RMP.  In the 
presence of a pyrethroid that blocks VGClCs, however, the hyperpolarizing  
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Figure 11:  Mechanism by which L-glutamate release from presynaptic nerve terminals is 
increased by the presence of deltamethrin.  An open triangle (∆) indicates that respective 
channel has been modified by deltamethrin. 
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rectification of VGClCs cannot take place and the membrane remains depolarized.  The 
subsequent increase in localized calcium influx at active release zones allow synaptic 
vesicles containing neurotransmitter to fuse with the presynaptic release machinery and 
release neurotransmitters into the synaptic cleft.  Neurotransmitter release is prolonged 
and results in a more-than-additive response seen with certain binary mixtures of 
pyrethroids.  
A second mechanism by which pyrethroids may elicit a more-than-additive 
response on L-glutamate release is by suppressing the activity of CaClCs, which are 
indirectly regulated by the metabotropic L-glutamate receptor (mGluR), part of the G-
protein coupled receptor (GPCR) (Fig. 13).   
Initially, the binding of released L-glutamate to the mGluRs associated with the 
synaptolemma of the presynaptic nerve terminal results in a conformational change of the 
GPCR activating the G-protein by binding GTP to the Gα subunit.  Upon activation, Gα 
and Gβγ subunit disassociation (due to activation of the complex by GTP) allows Gβγ to 
bind directly to two regions on the VGCC, the α1 subunit interaction domain (AID) and a 
sequence downstream in domain II (D2), ultimately inhibiting VGCC activity (De 
Waard, M. 1997; Symington, S.B. 1999) and decreasing neurotransmitter release.  GTP is 
then hydrolyzed to GDP since this subunit possesses GTPase activity, allowing Gα to 
eventually reassociate with the Gβγ complex.   
The Gβγ complex has also been implicated in the upregulation of PLC activity, as 
demonstrated by Symington et al. in Paramecium tetraurelia (Symington, S.B. 1999).  
PLC activity in calcium channel containing vesicles was further increased in the presence 
of deltamethrin (1 x 10-7 M), suggesting that deltamethrin enhances the Gβγ  
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Figure 12:  Mechanism by which intracellular signaling pathways increase L-
glutamate release from presynaptic nerve terminals in the presence of deltamethrin.  
An open triangle (∆) indicates that respective channel has been modified by 
deltamethrin. 
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activation of PLC (Symington, S.B. 1999) and these findings are consistent with the 
second mechanism by which pyrethroids may elicit a more-than-additive response on L-
glutamate release. 
Upon sustained stimulation of GPCR by excess L-glutamate, however, the G-
protein complex can stimulate phospholipase C (PLC) to hydrolyze phosphatidyl 
insositol-biphosphate (PIP2) (Iglesias, I. 2007) to yield diacylglycerol (DAG) and inositol 
triphosphate (IP3). IP3 diffuses through the cytosol and promotes release of calcium from 
intracellular stores in the endoplasmic reticulum (ER).  The mobilization of intracellular 
calcium in the presence of DAG then activates PKC (Cuellar, J.C. 2005).  Upon PKC 
activation, VGCCs in the active release zone of presynaptic nerve terminals become 
phosphorylated and allow an increase influx of extracellular calcium, which in turn 
activates neurotransmitter release.  The IP3-dependent calcium released from intracellular 
stores is also available to activate CaClCs, allowing chloride ions to flux out, which 
depolarizes the membrane.  If the membrane potential becomes more positive than the 
threshold values for VGSC and VGCC activation, these channels become inactivated, 
ultimately contributing to presynaptic inhibition (Graham, B. 1994; Meir, A. 1999).  If 
CaClCs are blocked by pyrethroids, however, the synaptolemma will not be depolarized 
and VGSC and VGCC will remain activated allowing the increased release of L-
glutamate, contributing to the more-than-additive response as seen with our pyrethroid 
binary mixtures.  
Overall, the implications from this research suggest that the more-than-additive 
response binary mixtures previously determined by Frisbie (Frisbie, R.K. 2006) 
(deltamethrin plus S-bioallethrin, deltamethrin plus β-cyfluthrin, deltamethrin plus 
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cypermethrin, and deltamethrin plus fenpropathrin) may present a cumulative risk to 
mammals since three of the four elicited the more-than-additive response at pyrethroid 
concentrations less than those needed to elicit salivation and choreoathetosis (Rickard, J. 
and Brodie, M.E. 1985).  Rickard and Brodie determined that 0.118 nmole deltamethrin / 
g brain tissue were needed to elicit salivation whereas 0.379 nmole deltamethrin / g brain 
tissue were needed to elicit choreoathetosis in rats.  In the binary mixtures of pyrethroids 
tested, only deltamethrin plus S-bioallethrin exceeded these levels.  Thus deltamethrin in 
binary mixture with β-cyfluthrin, cypermethrin, and fenpropathrin, however, are 
toxicologically relevant since these mixtures elicited the more-than-additive response at 
concentrations below the levels observed to elicit salivation and choreoathetosis and their 
actions likely contribute to the production of the neurotoxic symptoms of poisoning. 
Our findings suggest that ClC-2 and/or CaClCs are potential target sites for 
certain pyrethroids and likely are important in pyrethroid neurotoxicity.  To determine if 
one or both of these channels are modified by pyrethroids, the next line of investigation 
would entail heterologous expression of these channels from rat brain in Xenopus laevis 
oocytes using two-electrode voltage clamp to monitor chloride conductance in the 
presence and absence of selected pyrethroids.  Since ClC-2 rectify membrane potential, it 
would be expected that depolarizing the oocyte during a voltage-clamp experiment 
(raising the membrane potential above ECl) would cause an inward flux of chloride ions.  
In the presence of our most potent pyrethroid, deltamethrin, it would be expected that 
chloride channel activity would be inhibited and peak current should be abolished.  In the 
presence of a pyrethroid that does not modify VGClCs (e.g. tefluthrin), peak current 
should not be affected.   
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Heterologous expression of CaClCs would be expected to cause an outward flux 
of ions to resulting in a depolarization of the presynaptic nerve terminal and ultimately 
inactivating endogenous VGSCs and VGCCs.  In the presence of deltamethrin, these 
channels would not inactivate VGSCs and VGCCs, resulting in a sustained depolarization 
of the membrane.  Tefluthrin should not affect the gating kinetics of CaClC.  Findings 
from these experiments would be expected to reveal whether or not certain pyrethroids 
modify these channels directly and if they could contribute to the more-than-additive 
response on L-glutamate release seen using our synaptosomal preparations.   
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Appendix A.  The structural configurations of the chloride channel blockers used in this 
study.  
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Appendix B.  The structural configurations of the pyrethroids used in this study.  
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